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1. SUMMARY 
Graphene (G) has the potential to make a very significant impact on society, with new 
interesting and beneficial applications for both individuals and industrial organizations. 
The emerging interest toward applying G-based nanomaterials within the central nervous 
system (CNS) prompted us to focus our attention on the toxicity and biocompatibility of 
G nanostructures in contact with primary neuronal and glial cells. In this work we 
describe the interaction between G nanosheets and primary cortical astrocytes, which are 
key players in maintaining brain homeostasis, by exploring: (i) the molecular 
mechanisms of G nanosheets internalization, (ii) the changes in proteomic and lipidomic 
composition of G-treated cultures, (ii) the effects of G exposure on cell morphology and 
physiology and (iv) the indirect effects of G-exposed astrocytes on neuronal cells, in an 
astrocyte-neuron co-culture system. 
Primary astrocytes were exposed to pristine graphene (GR) and graphene oxide 
(GO) nanosheets at 2 concentrations (1 and 10 μg/ml) for 24, 48 and 72 h; exposed and 
control cultures were investigated combining different techniques ranging from cell 
biology to microscopy, electrophysiology, and “omics” approaches. Our results show 
that, although GR and GO nanosheets exposure did not affect cell viability, it did 
nevertheless cause morphological and physiological changes, including: i) alteration of 
cell shape due to disruption of cytoskeleton, ii) up-regulation of Kir 4.1 channels and 
glutamate uptake, iii) dysregulation of calcium homeostasis, iv) alteration of the 
expression level of proteins involved in fundamental cellular pathways, like neural 
development, metabolism, and trafficking, and v) variation of lipid content. Moreover, G-
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induced dysregulation of astrocyte physiology has an impact on the physiology of co-
cultured neuronal cells. 
Altogether, these results raise some concern on the safety of G nanosheets for 
future bio-applications, especially in the biomedical field. In this scenario, a detailed 
comprehension of the mechanisms controlling the interaction between G and CNS is 
mandatory, in the perspective of adopting this material for neuro-medical implants. 
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2. INTRODUCTION 
2.1 What is graphene? From its discovery to mass-production. 
G is a single- or few-layered sheet of sp
2
 hybridized carbon atoms covalently bonded to 
three other atoms arranged in a honeycomb lattice, with a thickness of only 0.34 nm. G 
was firstly isolated in 2004 by Drs. Geim and Novoselov in Manchester. They described 
and characterized a monocrystalline graphitic film obtained by a simple “scotch-tape 
method”, winning the Nobel prize in physics in 2010 for their groundbreaking work [1]. 
The method consisted in the repetitive mechanical exfoliation of graphite using adhesive 
tape, followed by pressing the tape against a substrate to obtain single or few layers of 
carbon atoms. Its unique structure endows G with a number of extraordinary properties: 
G is the thinnest compound ever known at one atom thick (a million times thinner than a 
human hair), the strongest compound discovered (between 100-300 times stronger than 
steel), it is light, transparent and flexible. It is extremely electrically and thermally 
conductive, which opens the possibility of using G in a broad spectrum of applications in 
electronics, optoeletronics, energy storage, medicine and environmental safety [2-4]. 
Since its discovery, the interest for G has increased exponentially in several 
scientific fields, with a high number of scientific publications per day reporting the 
general term “graphene”. It is therefore necessary to precisely catalog the components of 
the “G family”, since two-dimensional carbon materials with significant variations in 
layer number, lateral dimension, rotational faulting and chemical modification have been 
included under the same name (Figure 1)[5]. Materials made of no more than 10 layers, 
termed few layer graphene (layer numbers from 2 to about 5, .FLG) and multi layer 
graphene (layer numbers between 2 and about 10, MLG) can be classified as graphene 
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related materials (GRMs). In addition to the number of layers, the proper nomenclature of 
GRMs should include the specification of the chemical modifications, i.e. graphene oxide 
(GO) and reduced graphene oxide (rGO), and of the lateral dimensions, i.e. G nanosheets 
if one dimension is less than 100 nm, graphene microsheets if in a range between 100 nm 
and 100 µm, and graphene quantum dots (GQDs) if less than 10 nm. 
 
 
Figure 1. Representative scheme of GRMs. Modified from Kiev et al. [6]. 
 
The achievement of low cost and high yield production of G is still a major 
challenge. So far, depending on the final application of the material, the various synthesis 
methods can be categorized in: i) liquid phase and thermal exfoliation [7], ii) chemical 
vapor deposition (CVD) [8] and iii) synthesis on silicon carbide (Sic) substrates [9] 
(Figure 2). The process of liquid and thermal phase exfoliation consists in the ultrasonic 
exfoliation of graphite by solvent or thermal shock to obtain a single layer of G in 
suspension; in addition for G oxide production, graphite is firstly oxidized and then 
subjected to exfoliation. This technique has been applied for research purposes, in 
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particular G-based paints and inks are suitable for printable electronics [10] or biomedical 
applications, such as tissue engineering and regenerative medicine [11]. In the CVD 
process, a uniform G film is deposited on a surface of interest through a catalytic reaction 
between hydrocarbon gases and catalytic metal substrates. This method is suitable for 
applications in photonics, nanoelectronics [12] and for development of transparent 
biosensors and scaffolds to promote cells growth [4]. Finally, the synthesis of G on 
silicon carbide substrates is limited for niche applications like the manufacturing of high-
frequency transistors and other advanced electronic devices [13]. 
 
Figure 2. Methods of mass-production of G for different purposes. Modified from Novoselov 
et al. [2]. 
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2.2 Biomedical applications: interfacing graphene with the 
central nervous system. 
The central nervous system (CNS) is composed of two main cellular populations, neurons 
and glial cells, the latter category including astrocytes, microglia, pericytes and 
oligodendrocytes. Each cell type has specific functions and all together they contribute to 
maintain the homeostasis of CNS. Perturbations of any single component at the cellular 
and molecular level would disrupt this perfect equilibrium, leading to CNS pathologies. 
Traditional treatments for CNS disorders present a number of challenges; in this context, 
nanotechnology has emerged as a promising alternative for treating neurological diseases. 
Because of all its extraordinary properties, G has attracted attention for applications in the 
field of neurology. Possible applications of G and G-based materials include (i) the 
delivery to the brain of drugs/genes usually rejected by the blood-brain barrier (BBB), (ii) 
tissue engineering, as interfacing two (2D) or three dimensional (3D) G scaffolds with 
neural cells could be extremely advantageous for exploring and stimulating their 
electrical behavior to facilitate neuronal regeneration, and (iii) cell labeling and real-time 
monitoring of biological active molecules. All these points will be described in detail in 
the next paragraphs. 
However, interfacing G with the CNS requires a preliminary detailed toxicity 
profile both in vitro and in vivo. In particular, specific characteristics of G materials are 
known to influence its toxicity, such as its concentration, lateral dimension, charge and 
surface structure of the nanosheets [14, 15]. 
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2.2.1 Graphene for drug and gene delivery. 
One attractive possibility is to employ G for the therapeutic delivery of drugs that are 
usually rejected by the blood-brain barrier (BBB), loading cargoes to G via - stacking 
interactions, hydrogen bonding, or hydrophobic interactions [16]. To date, GO 
nanosheets are preferred with respect to GR nanosheets because of their major solubility 
and stability in biological fluids [17]. Moreover, the possibility to be functionalized with 
polyethylene glycol (PEG), poli(ε-caprolactone) (PCL), pluronic, amine, carboxyl and 
dextran groups to decrease toxicity and increase biocompatibility is a further advantage 
[18, 19]. 
Once injected intravenously, G can reach various locations through the 
bloodstream, and some side effects have to be taken into consideration because of the 
interaction with the biological environment. The interactions of G nanosheets with ions, 
salts and proteins result in the aggregation of the nanomaterial and in the formation of a 
protein corona that affects the biodistribution of the material and often triggers an 
inflammatory response [20]. Nanosheets can be phagocytosed by macrophages, inducing 
activation and release of pro-inflammatory cytokines [21], and interact with several blood 
components inducing haemolysis [22]. Last but not least, nanosheets could accumulate in 
the reticulo-endothelial system rather than in the tissue to which they are targeted [23]. 
Furthermore, crossing biological barriers is still a major concern. Particularly 
challenging is the passage through the BBB, that significantly limits the delivery of 
drugs, blocking ∼100% of large-molecule neuro-therapeutics and more than 98% of all 
small-molecule drugs [24]. An ideal method for transporting drugs across the BBB would 
deliver molecules in a controlled and targeted way, additionally avoiding any damage to 
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the barrier. Accordingly to Mendonca et al., systemically injected rGO nanosheets 
crossed the BBB through a transitory decrease in the BBB paracellular tightness and 
accumulated in the thalamus and hippocampus of rats [25]. On the contrary, 
functionalization of rGO with polyethylene glycol (PEG) usually used to improve 
biocompatibility of nanoparticles, induced BBB breakdown and astrocyte dysfunctions in 
vivo [26]. Recently, Xiao et al. used GQDs conjugated to a neuroprotective peptide. Once 
injected intravenously (i.v.) in murine model of Alzheimer disease (AD), they increased 
learning and memory, dendritic spines formation, and decreased pro-inflammatory 
cytokine levels [27]. In addition, new approaches have been developed to target brain 
parenchyma overcoming the BBB. In a recent study, an innovative nano-delivery system 
has been investigated, with high loading capacity and a pH dependent behavior. 
Researchers created GO@Fe3O4 nanocomposites conjugated to lactoferrin (Lf), an iron-
transporting serum glycoprotein that binds to receptors overexpressed at the surface of 
glioma cells and vascular endothelial cell of the BBB, in order to obtain Lf@GO@Fe3O4. 
Doxycycline, a drug used to treat glioma, was loaded on the surface of G by π-π stacking, 
creating Lf@GO@Fe3O4@DOX. In vitro studies of cytotoxicity and cellular uptake 
demonstrated that this system could be a suitable tool for drug delivery, as it is able to 
specifically target glioma cells [28]. 
All together, the aforementioned works provide good prospects for the 
development of G-based nanocarriers for drug delivery applications, keeping in mind that 
the biocompatibility and nanosafety of the material within the CNS has to be carefully 
evaluated in detail before thinking of applying this system to human patients. 
9 
 
Thanks to its high surface area, G can be loaded with both single-stranded DNA 
and RNA through hydrophobic and π–π stacking interactions, which makes it an 
extremely good candidate also for gene delivery [29]. Different strategies have been 
developed to optimize G as gene delivery platform. These include: the decoration with 
positively charged polymers (PEI, BPEI), dendrimers (PAMAM) and polysaccharides, 
which enhance gene transfection efficiency by promoting the interaction with the cell 
membrane and the electrostatic interactions with nucleic acids [30, 31]; the pegylation, 
previously demonstrated to enhance stability, biocompatibility and biodistribution of G in 
vivo [32]; functionalization with cell-penetrating peptides to enhance transfection 
efficiency [33]; combination with gold nanoparticles (AuNP) and gold nanorods (AuNr) 
to increase aqueous dispersibility and to improve photothermal effects upon NIR 
irradiation [34]; and functionalization with tumor specific cleavable linkers, in order to 
target specific types of tumors [35]. Unfortunately, to date very few studies successfully 
demonstrated therapeutic G-mediated gene delivery in vivo. Notably, Paul et al. 
developed a hydrogel able to release PEI-GO/pDNA
VEGF 
complexes, to delivery vascular 
endothelial growth factor (VEGF) in vitro and successfully in vivo in a rat model of 
myocardial infarction [30]. In another interesting work, Choi et al. fabricated an mRNA 
delivery system employing GO-PEI to target iPS cells [36]. 
In conclusion, viral vectors still remain the most efficient tool for gene delivery. 
Nevertheless, the development of non-viral systems might allow overcoming some 
limitations, such as the difficulties in accommodating long nucleic acids, batch-to-batch 
variations, elevated costs and the immunogenicity of viral vector systems. G-mediated 
gene delivery is indeed a promising approach to overcome these issues, however most of 
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the published studies are limited to in vitro models, and the in vivo validation of this 
system is strongly awaited. 
 
2.2.2 Graphene-based materials for tissue engineering and regenerative 
medicine 
Tissue engineering aims to restore and improve the disrupted functions of a tissue or an 
organ by interfacing them with suitable bioengineered materials. Active and dynamic 
implantable devices are extremely advantageous for both stimulating and recording 
electrical activity of neural cells. Researchers have developed various classes of 
implantable devices used as neural interfaces, including deep brain stimulation implants 
(DBI) for the electrical stimulation of deep structures in the brain, clinically used to treat 
dystonia and tremor in Parkinson disease [37], retinal and cochlear implants to 
electrically stimulate the surviving neurons in presence of retinal disease or to convert 
external sounds in electrical impulses [38, 39], central and peripheral nervous system 
stimulators, promising for motor rehabilitation after spinal cord lesions [40], and 
intracranial electrodes to map brain electrical activity, which are used for diagnostic 
purposes [41] (Figure 3). 
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Figure 3. G based neural interfaces for a variety of functionalities like recording, 
stimulation and biosensing. Modified from Kostarelos et al. [4]. 
 
The intrinsic properties of G can be exploited to design G-based devices for 
neural interfaces. Fundamental requirements for a good neural implant are: i) 
biocompatibility with minimal inflammatory response, ii) adequate signal-to-noise ratio 
(SNR) and iii) minimal invasiveness, respecting tissue integrity. To date, in vivo studies 
demonstrate that G electrodes can stimulate and record neural activity, to map brain 
functions and implement neural prosthetics. Recently, Kuzum et al. [42] developed a 
flexible, low noise G electrode for simultaneous electrophysiology and imaging recording 
in vivo. After bicuculline injection to evoke epileptiform activity, it was possible to 
record simultaneously from rat cortical hemispheres with G-electrodes and Au-electrodes 
of the same size. G electrodes displayed 6 times lower SNR with respect to Au-
electrodes, suggesting that the adoption of the new G-based recording system could offer 
clear advantages for studying brain electrical activity. In addition, thanks to the 
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transparency of G electrodes, it was possible to simultaneously image the cortical area, 
combining in vivo two-photon imaging and cortical electrophysiological recording [42]. 
A further progress has been achieved by developing G field effect transistors (G-
FETs), which allow signal amplification, reducing external noise. Exploiting these 
advantages, Veliev et al. [43] reported the fabrication of G-FETs on various substrates. 
They detected in vitro spontaneous activity of hippocampal neurons grown on top of the 
G sensors, with high sensitivity and low noise level [43]. Additionally, Blaschke et al. 
[44] successfully demonstrated the recording of in vivo brain activity of rats using G-
FETs. The researchers were able to record LFP during spontaneous slow oscillations, 
visually evoked activity, and pharmacologically-induced pre-epileptic spikes, with good 
biocompatibility, high spatial resolution and SNR, confirming the results obtained by in 
vitro studies and bringing an advance in G-based neural interface devices (Figure 4) [44]. 
 
Figure 4. Flexible G microtransitors to record brain activity. A. Representation of the G 
implant. B. Representation of the implant located on the surface of the rat brain. C. 
Characterization of the device. Taken from Blaschke et al. [44]. 
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2.2.3 Bioimaging and biosensing 
G materials have also been employed for bioimaging applications as imaging contrast 
agents due to their intrinsic fluorescent emission, raman scattering, and near infrared 
spectroscopy (NIR) absorbance [45], as carriers of dyes, like Cy5, Cy7, IRDye 800 and 
fluorescein [46], and as fluorescence quenchers via fluorescence resonance energy 
transfer (FRET) or charge transfer [47, 48]. Remarkably, the unique structure and optical 
properties of GQDs make them the most used G materials for cell and tissue imaging 
[49]. GQDs usually show typical absorption bands in the UV region, with a range of 
emission from ultraviolet to near-infrared, depending on the size and specific 
functionalization of the material [45]. A number of studies report good labeling of 
different cell types in vitro [50]; moreover, functionalization of GQDs with poly (l-
lactide) PLA and PEG allow intracellular imaging of miRNA combined with gene 
delivery [51]. However, in vivo imaging presents many challenges due to 
autofluorescence of tissues and light scattering effects and until now the fluorescent 
signal of GQDs in deep tissues or organs has been neither detected nor demonstrated. 
The fluorescence quenching ability of GO has been expoited to develop 
biosensors able to detect dye-labeled ssDNA [52]. Interestingly, the interaction between 
GO and dye-labeled ssDNA allows to quench the fluorescence of the fluorophor, making 
this tecnique suitable for sensing molecules like glucose [53]. Glucose detection is also 
possible through a G-based enzymatic reaction: the covalent attachment of the amine of 
glucose oxidase to the carboxylic groups of GO creates a biosensor able to detect glucose 
levels [54]. In addition, also NADH, cholesterol, cytocrome C, hemoglobin, H2O2 and 
other analytes could be detected by G-based enzymatic and non-enzymatic reactions [55]. 
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Of note, G-based biosensors have been developed for detection of 
neurotrasmitters, exemplified in the work of Hess et al., in which enzyme-modified G 
FETs were developed to detect acethylcholine, a neurotrasmitter in CNS and PNS [56]. In 
a similar work, functionalized G was used for the detection of dopamine [57]. To 
conclude, different promising strategies have already been succesfully explored, 
especially in in vitro systems; however further studies are necessary to test and make this 
technologies working in vivo. 
 
2.3 Toxicity of graphene materials in the central nervous 
system. 
2.3.1 Characterization of graphene materials 
The determination of the common mechanisms of G toxicity when in contact with 
biological systems is still a major challenge, as multiple parameters that are specific for 
each G material have to be taken into account. The Graphene Flagship programme, a 10 
year European project, was set up with the purpose to coordinate G research among 
European universities, research centers and companies, bringing together academic and 
industrial researchers. One of the main aims of the flagship is to reveal correlations 
between the material structure and its toxicological effects. So far, the biological 
correlation of G properties such as layer number, lateral dimension, surface chemistry, 
surface volume/ratio, and material purity has already been analyzed on different cell 
types [58]. The layer number determines the thickness, the specific surface volume/ratio, 
and bending elasticity. From a biological point of view, the absorption capacity of 
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biological molecules increases significantly as the surface/volume ratio increases. For 
monolayer G, the surface/volume ratio is maximized, due to atoms lying on its surface 
and exposed to the surrounding medium; by contrary, the increase in layer number leads 
to a reduction in surface volume/ratio, which in turn decreases the adsorption capacity of 
the material. Of note, as the lateral size of G ranges from the nanoscale to the microscale 
(i.e., 10 nm up to >20 μm), it is crucial to specify the lateral dimension of each sample to 
be able to predict its biological effects. Furthermore, it has been demonstrated that NPs 
with diameter size <100 nm can easily enter the cell, NPs <40 nm can enter nucleus, and 
if <35 nm may cross the blood-brain barrier [59]. Another fundamental parameter to take 
into consideration is the surface chemistry, being GR and GO extremely different in their 
surface hydrophobicity/hydrophilicity. GR surface is hydrophobic, while GO presents 
hydrophobic islands as well as hydrophilic regions, which confers the material highly 
dispersibility in biological media due to the presence of oxygenated functional residues 
like epoxide, carboxyl, and hydroxyl groups. Together with the lateral size, the exposed 
charge might also significantly affect G internalization in cells and tissues, as well as 
drive the cellular endocytosis pathways. The main internalization routes could be divided 
in 4 main categories: (i) clathrin-mediated endocytosis, (ii) caveolae-mediated 
endocytosis, (iii) micropinocytosis and (iv) phagocytosis. Notably, it has to be considered 
that the extent of G internalization is dependent on the cell type [60]. Macropinocytosis 
seems to be a general mechanism of internalization, however Linares et al. showed that 
besides macropinocytosis, pegylated-GO can enter osteoblasts cells through pathways 
dependent on microtubules, and through clathrin-dependent mechanisms in hepatocytes 
and macrophages cell lines [60]. 
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  In order to coordinate research in different biomedical fields, an in the attempt to 
obtain results that are comparable between different research groups, the Flagship Work 
Packages dealing with the investigation of the biological interaction of G with living 
systems have selected the few-layer GR and monolayer GO nanosheets used throughout 
this work and object of this thesis. The material was provided and characterized by Dr. 
Vazquez’s group (University of Castella La Mancha, Spain). GR nanosheets were 
prepared by exfoliation of graphite through interaction with melamine by ball-milling 
treatment. After exfoliation, melamine could be easily removed by filtration to obtain 
stable dispersions of few-layer graphene to reach a final concentration 0.09 ppm in H2O 
[61]. Monolayer GO is commercially available and provided by the Grupo Antolin 
Ingenieria by oxidation of carbon fibers [62]. Initial GO suspensions were washed with 
water to remove the presence of acids and were fully characterized. The elemental 
analysis gave the following results (as percent weight): 47.71 ± 0.03 wt % C, 3.04 ± 0.02 
wt % H, 0.15 ± 0.01 wt % N, and 0.27 ± 0.03 wt % S. Oxygen content was therefore 
calculated at ca. 48% by weight.  
Zeta-potential, a measure of the electrostatic potential at the electrical double 
layer surrounding a nanoparticle in solution [63], was also measured. Nanoparticles with 
a zeta potential between -10 and +10 mV are considered approximately neutral, while 
nanoparticles with zeta potentials greater than +30 mV or less than -30 mV are 
considered strongly cationic and strongly anionic, respectively. Zeta-potential values for 
the G nanosheets used in this study were estimated around −35 mV at physiological pH. 
Dynamic light scattering (DLS) and transmission electron microscopy (TEM) analysis 
revealed a higher lateral size distribution of GR (500−2000 nm) compared to GO (100−
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1500 nm) nanosheets. Moreover, Raman spectroscopy, a vibrational technique that is 
extremely sensitive to geometric structure and bonding within molecules, was used to 
provide a further characterization of G materials [64]. Even small differences in 
geometric structure lead to significant differences in the observed Raman spectrum of a 
molecule. The spectra of G materials are characterized by two principal bands designated 
as the G band and 2D bands; a third band, identified as D, band may also be present when 
there are defects within the carbon lattice (Figure 5 A). The G band is a sharp band that 
appears around 1587 cm
-1
 in the spectrum and its position is highly sensitive to the 
number of layers; the intensity of the band is also a measurement of layer thickness 
(Figure 5 B-C). The 2D band is used to determine G layer thickness too, based on 2D 
band shape (Figure 5 D). In addition, the intensity ratio of the 2D to G band (I2D/IG) 
identify high quality (defect free) single layer G (when equal to 2) [64]. 
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Figure 5. A The Raman spectra of graphite and graphene. B. The G band position is a function of 
layer thickness. As the number of layers increases, the band shifts to a lower wave number. C. 
There is a linear increase in G band intensity, as the number of G layers increases. D. The 2D 
band exhibits distinct band shapes depending on the number of layers. Modified by Wall [65]. 
 
The G nanosheets used through the next studies exhibited G and 2D modes 
around 1573 and 2700 cm−
1
, respectively, which satisfy the Raman selection rules. When 
G is affected by defects Raman spectroscopy showed a D peak around 1345 cm−
1
 (Figure 
6 A). The intensity ratio between the D and the G band was calculated at different 
locations and used to quantify defects on the G surface, giving a significant low value for 
GR (0.22 ± 0.05; n = 5) compared to GO (0.81 ± 0.05; n = 5). Finally, thermogravimetric 
analysis (TGA) was also used to quantify the degree of functionalization of these 
materials. The low weight loss observed in GR (7%) corroborated the low quantity of 
oxygen groups generated by the exfoliation process in comparison to the values obtained 
for GO (46%) (Figure 6 B). 
 
Figure 6. Characterization of GR and GO nanosheets. (A) Raman spectroscopy; (B) 
thermogravimetric analysis. Modified by Bramini et al. [62]. 
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2.3.2 Graphene biocompatibility for applications to the central nervous 
system. 
Each biomedical application requires specific tests to assess G biocompatibility. For 
example, when using G-based materials for drug delivery purposes, it is fundamental to 
test concentration-dependent cytotoxicity, to investigate the mechanisms of cytotoxicity 
in vitro and to probe the biodegradability of the material in vivo. On the other hand, when 
employing G scaffolds for tissue engineering purposes, it is mandatory to monitor their 
chemical and mechanical stability, biocompatibility and long term toxicity, to avoid the 
onset of chronic inflammation. 
Focusing on CNS, a recent work of Bramini et al. [66] pointed the attention on the 
effect of chronic and acute exposure of rat primary cortical neurons to GR and GO 
nanosheets, described in the previous paragraph (Figure 7). Chronic GR and GO 
exposure did not cause alterations in cell viability, excitability, and network formation. 
However, a more detailed investigation on cell functionality revealed some 
pathophysiological effects specific to GO exposure, such as the inhibition of excitatory 
transmission accompanied by a reduction in the number of excitatory synaptic contacts 
and by a concomitant enhancement of the inhibitory activity; the induction of autophagy; 
altered Ca
2+
 dynamics, and downregulation of the main players in the regulation of Ca
2+
 
homeostasis, in both excitatory and inhibitory neurons (Figure 8) [62]. Accordingly, 
work from a different group confirmed that a concentration of 10 µg/ml of GO 
nanosheets interfered with synaptic signaling. In particular a reduction in frequency of 
spontaneous post-synaptic currents (PSC, mPSC), accompanied by a marked reduction in 
VGLUT1-positive puncta, was noticed. Moreover, a reduction in active neurons, 
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explored by Ca
2+
 imaging, a decrease in recycled vesicles and alteration of the kinetic of 
vesicle recycling were also noticed upon GO treatment [66]. All these findings point the 
attention on the biocompatibility of G nanosheets within the CNS; studies on the effects 
of G nanosheets exposure with other CNS cell types are still missing and are mandatory 
for every future application, in order to improve the design and engineering of G based 
technologies. 
 
Figure 7. G-nanosheets interaction with neuronal cells. A-D. Neurons were exposed to GR 
and GO flakes 96 h, and 14 days, fixed, and prepared for SEM analysis. A large number of flakes 
(white arrowheads) were found in contact with the cell membrane; however, cell morphology and 
network development were substantially unaffected. E-H. Intracellular localization of G 
nanosheets was studied by TEM. Starting from 96 h of incubation G nanosheets were internalized 
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into intracellular vesicles (E, H black arrowheads) or free in the cytoplasm (H, black arrowheads). 
Modified from Bramini et al. [62]. 
 
 
 
Figure 8. Ca
2+
 dynamics and spontaneous synaptic transmission in cortical neurons treated 
with GO for 14 DIV. A. Representative spontaneous (left panels) or bicuculline-evoked (right 
panels) Ca
2+
 oscillations recorded in 14 DIV cortical cultures treated with either vehicle (Ctrl) or 
10 μg/mL GO for 14 days. (B) Percentages of spontaneously active cells (C) and mean resting 
Ca
2+
 concentrations measured at the cell body level (D) The frequency of Ca
2+
 oscillations under 
basal conditions or in the presence of bicuculline (20 μM) displayed lower values for GO-treated 
neurons. Data are means ± SEM. *p < 0.05, **p < 0.01, two-tailed Student’s t-test; n = 30 cells 
per experimental condition, from 4 independent neuronal preparations. (E-H) Activity of 
excitatory and inhibitory synapses in primary cortical neurons treated with GO for 14 days. (E) 
Representative recordings of miniature excitatory postsynaptic currents (mEPSCs) in cortical 
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neurons treated with GO (10 μg/mL) or vehicle. (F) Cumulative distribution of inter-event 
intervals and mean (±SEM) frequency of mEPSCs in control and GO-treated neurons. (***p < 
0.001, one-way ANOVA and Bonferroni’s multiple comparison test; n = 15 cells from 2 
independent neuronal preparations) (G) Representative recordings of miniature inhibitory 
postsynaptic currents (mIPSCs) in cortical neurons treated with GO (10μg/mL) or vehicle. (H) 
Cumulative distribution of inter-event intervals and mean (± SEM) frequency of mIPSCs in 
control and GO-treated neurons. Modified from Bramini et al.[62]. 
 
 For what concerns G scaffolds, in vitro studies demonstrated the viability of 
neuronal cells grown on planar 2D G-substrates, highlighting the ability of G-scaffolds to 
promote neuronal growth and differentiation, and to stimulate neuronal activity [67]. 
Moreover, previous works established that G films promote differentiation of hNSCs 
toward neurons with respect to glia cells, compared to hNSCs grown on standard glass 
substrates (Figure 9) [68]. Accordingly to Wang et al. [69] fluorinated G substrates 
promote the differentiation of mesenchymal stem cells (MSCs) towards neuronal lineages 
via spontaneous cell polarization. These phenomena have been imputed to the G aromatic 
scaffold, which increases the local concentration of extracellular matrix (ECM) such as 
collagen, laminin and fibronectin by non-covalent binding. Intriguingly, interfacing 
mouse hippocampal neurons on 2D G-substrates resulted in an increase in neurite number 
and length compared to cells cultured on polystyrene substrates. 
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Figure 9. Neuronal differentiation of hNSC on G films. A. Bright-field images of the hNSCs 
differentiated at different time points. Note that the hNSCs on glass were gradually retracted and 
detached after two weeks, while those on G remained stable even after three weeks of 
differentiation. B. Bright-field (top row) and fluorescence (bottom row) images of hNSCs 
differentiated on glass (left) and G (right) after one month differentiation. The differentiated 
hNSCs were immunostained with GFAP (red) for astroglial cells, TUJ1 (green) for neural cells, 
and DAPI (blue) for nuclei. Note that more hNSCs were adhered to G than to glass. C. Cell 
counting per area on G and glass regions after one-month differentiation. (n = 5, p < 0.001). D. 
Percentage of immunoreactive cells for GFAP (red) and TUJ1 (green) on glass and G. (n = 5, p < 
0.05). Modified from Park et al.[68]. 
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 However, the unique properties of planar 2D-G scaffolds are exceeded by 3D-G 
structures, which provide a microenvironment where cells are able to grow under 
conditions that are closer to the in vivo situation. In addition, 3D-G structures possess an 
enormous interface area and provide highly conductive pathways for charge transport, 
useful to support neural network formation and neural regeneration. Li et al. firstly 
described 3D-G foams (3D-GFs) as scaffold for NSCs growth and proliferation. NSCs 
grown on 3D-GFs were able to differentiate into neurons and astrocytes; moreover, it was 
also demonstrated that 3D-GFs were optimal platforms for electrical stimulation of NSCs 
in order to enhance their differentiation (Figure 10) [70]. Ulloa et al. [71] showed that 
hippocampal neurons cultured on 3D-GFs possess a more extensive connectivity 
associated with an higher synchronization of network with respect to 2D-G substrate 
systems, mimicking the physiological properties of the brain. 
New generation of 3D-G scaffolds combine the advantages of hydrogels, able to 
mimic soft tissue, with the properties of G. Hybrid G-based hydrogels, synthesized 
mainly using GO, G oxide peroxide (GOP), or even rGO, are able to support neuronal 
growth and the development of synaptic activity [72]. These results underline the 
innovation of G scaffolds to engineer the neural interface devices of the future, 
introducing the importance of dimensionality, as well as electrical conductivity, in 
neuronal network dynamics and development. 
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Figure 10. NSC adhesion and proliferation on 3D-GF. A, B. Low and high-magnified SEM 
images of NSCs. C. Cell viability assay of NSCs cultures on 3D-GFs. D. Immunostaining for 
Nestin (marker of NSCs, green) and DAPI (marker of nuclei, blue). E-F Immunostaining (E) and 
western blot analysis (F) of Nestin and Ki67 (marker of proliferation). Modified from Li et al. 
[70]. 
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2.4. Astrocytes in physiology and pathology. 
Astrocytes are part of multicomponent synapses formed by the presynaptic terminal, the 
postsynaptic neuron, the peri-synaptic processes of astrocytes, the processes of 
neighboring microglial cells that periodically contact the synaptic structure, and the 
extracellular matrix (ECM), which is present in the synaptic cleft and also extends 
extrasynaptically.  In vivo, astrocytes can be categorized in different subtypes by cell 
morphology and anatomical locations. Protoplasmic astrocytes are found predominantly 
in gray matter, characterized by numerous fine branches, whereas fibrous astrocytes are 
found throughout all white matter, characterized by less fiber-like processes than the 
protoplasmic ones [73]. Moreover, the cerebellum contains specialized astrocytes called 
Bergmann glia; they are characterized by small cell bodies with few processes that form 
close contacts with synapses. It should be taken into account that astrocytes in vitro lose 
part of the complexity observed in vivo, exhibiting a flat, epithelioid morphology due to 
the nature of the standard, two-dimensional culturing system [74]. 
Nowadays astrocytes are no longer seen only as support cells; indeed, they play 
essential functions in CNS homeostasis. Since the discovery of voltage dependent ionic 
channels in their cell membrane, astrocytes gained an overall different biological 
significance in the regulation of brain physiology [75]. In fact, besides defining the brain 
micro-architecture, astrocytes control extracellular homeostasis regulating concentrations 
of ions, pH and transmitters in the extracellular milieu (Figure 11). Notably, they are 
involved in a process termed “potassium spatial buffering” thanks to inwardly rectifying 
potassium channel (Kir) [76]. Astrocytes also regulate neuronal activity by removing 
excess of glutamate via the glutamate transporters GLAST and GLT1, thus avoiding 
27 
 
network hyperexcitation [77]. The role of Kir channels and glutamate clearance in the 
physiology and pathology of astrocytes will be described in detail in the next paragraph.  
In addition, astrocytes are the central elements of neurovascular units and control 
the local blood flow by releasing prostaglandins, nitric oxide, and arachidonic acid, that 
can increase or decrease CNS blood vessel diameter and blood flow [78]. 
 
 
Figure 11. Astroglial channels involved in extracellular homeostasis. Modified from Ferroni 
et al. [79]. 
Astrocytes are also characterized by a complex modulation of Ca
2+
 events that 
coordinate their major functions, and in turn influence neuronal activity. The dynamics of 
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intracellular astrocytic calcium [Ca
2+
]i fluctuations have been  intensely investigated in 
recent years. Increase of [Ca
2+
]i can be triggered by transmitters released during neuronal 
activity, such as γ-aminobutyric acid (GABA) [80], glutamate [81], and ATP [82], which 
bind to G-protein-coupled receptors (GPCRs) that activate the pathway of inositol-3-
phosphate (IP3). Once at the ER, IP3 binds to a ER-resident ligand-gated Ca
2+
 channel, 
inducing the opening of the channel and the consequent diffusion into the cytoplasm of 
Ca
2+
 stored in the ER, thus effectively rising [Ca
2+
]i [83]. Increases of [Ca
2+
]i in turn 
induce release of chemical transmitters, so called “gliotransmitters”, from astrocytes. 
Gliotransmitters include ATP, glutamate, D-serine and GABA, which can modulate 
neuronal activity post-synaptically [84] and transmitter release probability at presynaptic 
sites [85, 86]. In addition, [Ca
2+
]i rise spreads along astrocyte processes and even between 
adjacent glial cells through the gap junctions, permitting long-distance propagation of the 
Ca
2+
 waves [84]. At vascular endfeets, Ca
2+
 waves induce the release of vasoactive 
messengers such as arachidonic acid, prostaglandins, 20-hydroxyeicosatetraenoic acid, 
epoxyeicosatrienoic acids, phospholipase C and adenosine [78]. Various studies have 
reported that dysregulation or malfunctioning of Ca
2+
 signaling in astrocytes could play a 
major role in different neurological disorders, like epilepsy [87], Alzheimer’s disease [88] 
and Huntington’s disease [89]. In fact, excess of Ca2+ released from the ER stores induces 
an exaggerated gliotransmission, which can have important effects on neuronal activity 
and blood flow regulation [78]. 
 Of note, astrocytes secrete factors involved in synaptogenesis, regulating 
fundamental processes such as the number of synapses [90, 91], postsynaptic activity by 
up-regulation of AMPA receptor expression [92], and presynaptic release by increasing 
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release probability [93]. Astrocytes are also involved in synapse elimination through two 
different mechanisms, i.e. the release of TGF-β, which in turn induces the expression of 
C1q on synapses to be pruned, activating complement-dependent phagocytosis by 
microglia [94-96], and the direct phagocytosis of silent synapses by recognizing specific 
signals on their surface [97]. 
Furthermore, astrocytes are able to respond to CNS insults such as infections, 
traumas, ischemia, and neurodegenerative diseases, by a process commonly referred as 
"reactive astrogliosis". This is characterized by an increase in astrocyte number, up-
regulation of glial fibrillary acidic protein (GFAP), migration to the injury sites, 
formation of glial scar and modulation of the inflammatory response [98]. Reactive 
astrocytes belong to two different categories, termed A1 and A2 astrocytes, and are 
characterized by a specific proteomic profile [99]. In an elegant study by Lidellow et al. 
[100], it has been demonstrated that A1 astrocytes, activated by release of cytokines from 
microglia cells, are involved in neurodegeneration, including neural cell death and 
impairment in synapses formation. Indeed, A1 reactive astrocytes have been found in 
brain regions involved in neurodegeneration in a variety of human pathologies, including 
Alzheimer’s disease, multiple sclerosis, Parkinson’s disease, and Huntington’s disease. 
By contrary, A2 astrocytes have neuroprotective functions trough release of 
neuroprotective factors, phagocytosis of synapses and clearance of debris and dead cells 
[100]. 
Investigations on the role of astrocytes in CNS are still open to clearly elucidate 
the link between microglia, astrocytes, neurons and the BBB under physiological and 
pathological conditions. In this scenario, development of new strategies to treat CNS 
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pathologies cannot overlook the potential of astrocytes as targets to promote repair in 
disease, as well as the pathological effects induced by astrocyte dysregulation. 
2.4.2 Potassium and glutamate homeostasis of astrocytes under 
physiological and pathological conditions.  
Several pieces of evidence have identified ion channels and transporters as key players in 
the physiology of astrocytes. Therefore, any physiological and pathological conditions 
that alter the expression and/or the functionality of these plasma-membrane proteins will 
invariably affect the neuronal network [79]. Numerous studies have identified diverse ion 
channels and transporters whose expression and activity can be modified according to the 
functional states of the astrocytes. In vivo fully differentiated astrocytes express a large 
K
+
 conductance, which is associated to the expression of inward rectifying K
+
 channels 
[76]. There are 7 different Kir subtypes, classified according to their different 
electrophysiological and molecular properties; however astrocytes predominantly express 
the weakly rectifying Kir 4.1 channels, encoded by the KCNJ10 gene [101]. Low 
expression of heteromeric channels formed by Kir 2.1 and Kir 5.1 subunits has also been 
reported [102]. In astrocytes, Kir 4.1 expression is heterogeneous throughout the brain 
and spinal cord [103-105] and increases during development [106, 107]. The role of Kir-
mediated current in buffering extracellular K
+ 
has been widely reported; under 
physiological conditions, during normal neuronal activity, astrocytes remove excess K
+ 
from the extracellular space through Kir 4.1 channels, redistributing it at distant sites 
where extracellular K
+
 is low [108]. Genetic ablation of Kir4.1 in astrocytes impairs the 
homoeostasis of extracellular K
+
 [109, 110]. Since Kir4.1 displays weakly rectifying 
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properties and lack of intrinsic voltage dependence, it allows both the influx end efflux of 
K
+
 according to the electrochemical gradient, thus contributing to set the very negative 
resting membrane potentials of astroglial cells in situ [110]. Of note, this negative resting 
membrane potential is critical also for the regulation of the Na
+
-dependent uptake of 
glutamate, which is favoured by negative membrane potentials [109]. 
Decreased Kir current in astrocytes is a hallmark of epileptic tissue [111, 112], 
and downregulation of Kir channels was also reported in reactive astrocytes few days 
following global cerebral ischemia [113]. Moreover, K
+
 conductance was found to be 
depressed few days after traumatic brain injury, a condition that causes K
+
 accumulation 
in the extracellular space and an alteration of neuronal activity [114]. Additionally, 
reduced Kir 4.1 expression was displayed by mouse models of neurodegenerative 
diseases characterized by an impairment of K
+
 homeostasis such as amyotrophic lateral 
sclerosis (ALS) and Huntington’s disease (HD) [115-117]. 
Astrocytes are also responsible for regulating neuronal activity by removing 
excess of glutamate via the glutamate transporters. Five transporters for glutamate have 
been cloned, named Excitatory Amino Acid Transporter (EAAT)1-5 [118, 119]. Among 
these, EAAT1 (GLAST) and EAAT2 (GLT-1) are the most expressed at astrocytic 
plasma membrane. GLT1 and GLAST have different localization in the brain [120] and 
are developmental regulated [121]. While GLAST is present in rat forebrain and 
cerebellum at birth, GLT-1 is expressed at postnatal week 3 and reaches the adult pattern 
by week 5. In the adult brain, GLT-1 expression is most abundant in forebrain regions 
[122], with the highest astrocyte GLT-1 levels in caudate nucleus, cortex, and 
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hippocampus. A recent work demonstrated that neuronal factors determine the specific 
expression of GLT-1 and GLAST in different brain areas   
At the synaptic cleft glutamate concentration can increase transiently from 
<20 nM to 1 mM following action potentials [123],while cytosolic glutamate ranges from 
1 to 10 mM in different cell types [124]. As glutamate is not metabolized upon release, 
under physiological conditions astrocytes maintain extracellular glutamate concentration 
below toxic level to prevent neuronal hyperexcitability or receptors desensitization [77]. 
They regulate glutamate clearance both by the changing the expression of glutamate 
transporters, and by modifying the transporter activity. It is known that treatment with 
dibutyryl-cAMP or other growth factors, associated with morphological and biochemical 
astrocyte maturation, induces expression of GLT-1 and increases expression of GLAST 
in astrocyte cultures. Altered expression of GLT-1 and GLAST is linked to 
neurodegenerative diseases, including traumatic brain injury, hypoxic/ischemic insults 
[125], epilepsy [126, 127], glioma [128] and amyotrophic lateral sclerosis [129]. The 
levels of GLT-1 and/or GLAST proteins are also lower in brain tissue from patients with 
amyotrophic lateral sclerosis [130], epilepsy [131], Alzheimer's disease [132] and 
Huntington's disease [133]. 
Glutamate clearance is also regulated by changes in transporters activity; in fact, 
GLT-1 and GLAST are antiporters that carry one molecule of glutamate inside the cells 
along with three Na
+
 and one H
+
, while exporting one K
+
. These transporters are 
electrogenic, taking up glutamate much more effectively at negative resting potentials. 
Considering that Kir 4.1 channels are responsible for maintaining a negative resting 
potential in astrocytes cells, Kir 4.1 channels ensure maximal glutamate transport rates 
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via GLT-1 or GLAST. As matter of fact, knock-down of Kir 4.1 by RNA interference, as 
well as inhibition of Kir channels with 100 µM Ba
2+
, inhibits glutamate clearance, 
highlighting the role of membrane hyperpolarization in glutamate clearance [134]. 
Moreover, it has also been demonstrated that knockout of Kir4.1 in vivo reduced 
glutamate uptake [109] leading to seizure susceptibility in mouse [112]. 
2.4.3 Interaction between astrocytes and graphene materials. 
In view of its many potential biomedical applications, it is critical to understand the 
effects that G have on astrocytes due to their key role in regulating brain homeostasis. So 
far very limited data are available on this topic. Rauti et al. [66] demonstrated that GO 
nanosheets do not alter astrocyte viability in vitro, but affect the ability of astrocytes to 
release synaptic-like microvesicles that are involved in neuron-astrocyte communication. 
Mendonca et al. [25], instead, focused their studies on the effects of rGO nanosheets in 
vivo. After systemic administration of rGO, no changes in astrocyte viability and glia 
reactivity were found in the hippocampus of rats. By contrast, they demonstrated that 
PEGylation of rGO induced cytotoxicity of astrocytes in vitro affecting cell viability, 
morphology and ROS production at the very high concentration of 100 g/ml for 24 h 
(Figure 12). In vivo studies demonstrated that the intravenous injection of pegylated 
rGO (rGO-PEG) leads to a reduction in GFAP expression in rats hippocampus after 3 h 
and 7 days post injection and to the concomitant increase in antioxidant enzymes 
involved in detoxification of excess ROS. These data demonstrated the dose- and time-
dependent toxicity of rGO-PEG for astrocytes, speculating oxidative stress-mediated 
damage as a possible mechanism of toxicity [26]. These few studies highlight the 
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importance of a specific toxicity profile for each G-materials also when working with 
astrocytes. 
 
Figure 12. Effects of rGO and PEG rGO on astrocyte cultures. A. Astrocyte viability after 24 
h incubation with 10 and 100 g/ml of rGO and rGO-PEG. The percentage is given in relation to 
control medium and the columns are mean ± SEM (n=4). B. Analysis of cell viability using 
xCELLigence system. The curves represent the average of four individual well ± SEM of a 
representative experiment. C-H Representative images of GFAP (red) and aquaporin 4 (green) 
after incubation with vehicle (C,F), rGO 100 µg/ml and (D,G) rGO-PEG 100 µg/ml incubation 
(E,H). Modified from Mendonca et al. [26]. 
  
As far as G scaffolds are concerned, in vitro studies demonstrated that 2D and 3D 
G-scaffolds enhance glial differentiations from adipose stem cells [135] and neural stem 
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cells [70], supporting the biocompatibility of G substrates and their ability to promote 
cellular differentiation. In vivo studies reported that G scaffolds implanted in different 
brain regions reduce glial activation and the formation of the glia scar, compared to 
scaffolds not G-functionalized [136]. However, most of these in vitro and in vivo studies 
present limitations, of which the main is that astrocyte viability and reactivity is evaluated 
only based on the quantification of glial fibrillary acidic protein (GFAP). Little or nothing 
has been reported on the functionality, proteomic, lipidomic and gene expression profile 
of astrocytes exposed to GRMs, neither the mechanisms of G toxicity have been 
elucidated. Further studies are then needed to clarify these points and represent the aim of 
this thesis. 
 
2.5 Impact of graphene nanosheets on primary astrocytes  
On the basis of these considerations, previous work of our group aimed at testing the 
biocompatibility of GR and GO nanosheets with primary astrocytes cell. GR nanosheets 
were prepared by exfoliation of graphite through interaction with melamine by ball-
milling treatment [137]; GR/H2O dispersions were obtained at a final concentration of 
0.09 mg/ml in Milli-Q water, with a lateral size distribution of  500−2000 nm. Melamine 
traces were estimate to be 0,09 ppm. Monolayer GO was provided by the Grupo Antolin 
Ingeniería (Burgos, Spain) by oxidation of carbon fibers; GO/H2O dispersions were 
obtained at a final concentration of 0.5 mg/ml in Milli-Q water, with a lateral size 
distribution of 100-1500 nm (Figure 13). G nanosheets characterization has been 
described in detail in paragraph 2.3.1. 
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Figure 13. A, B Representative images of GR (A) and GO (B) nanosheets by transmission 
electron microscopy. Lateral dimension distribution of GR (A; 500-2000 nm) and GO (B; 100-
1500 nm) nanosheets by dynamic light scattering analysis. Modified from Bramini et al. [62] 
 
Astrocyte physiological response to prolonged exposure to G nanosheets was 
characterized. Primary astrocytes were isolated from neonatal rat brain cortices were 
exposed to either GR or GO nanosheets for 1-3 days to assess the effects of short- and 
long-term G exposure (Figure 14). Exposure to G-materials was not harmful to primary 
astrocytes at any of the concentrations and exposure times tested (Figure 14a-d). No 
appreciable effects on cell viability were also observed when confluent mature astrocytes 
were treated for 48 h with either GR and GO nanosheets, similarly to what observed 
upon early exposure (Figure 14 d). In summary, these results clearly indicate that 
exposure to G nanosheets did not affect astrocyte survival and therefore did not induce 
astrogliopathy caused by a loss of astrocyte viability [138]. 
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Figure 14. Viability of primary astrocytes exposed to GR and GO nanosheets.  
(a-c). Primary rat astrocytes were exposed to GR and GO nanosheets (1 and 10 g/ml) for 24 h 
(a), 72 h (b) and 7 days (c), or to the equivalent volume of the respective vehicles (Ctrl: 0.09 ppm 
melamine / H2O for GR flakes, H2O for GO flakes). Staurosporine (POS; 1 μM) was used as a 
positive control for apoptosis. Cell death was evaluated by flow cytometry analysis of Annexin-V 
(AxV, for early apoptotic events) and Propidium Iodide (PI, for late apoptosis) staining. The 
percentages of AxV- and PI-positive cells with respect to the total number of cells were 
calculated for each experimental group. (d) The same experimental procedure was carried out for 
primary glial cultures at confluence, exposed for 48 h to either GR or GO nanosheets. No 
significant changes in cell death were observed under all the experimental conditions (45,000 
cells from n = 3 replicates per experimental condition, from 3 independent preparations) (Bramini 
et al, unpublished data).  
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To get a comprehensive understanding of the intracellular pathways that are 
affected by G materials, proteomic analysis was carried out on independent preparations 
of primary astrocytes treated with either GR or GO nanosheets for 72 h, in collaboration 
with the IIT D3 Pharmachemistry department (Drs. Armirotti and Bandiera). Untargeted 
LC-MS/MS based proteomics was performed by labellng proteins from astrocytes 
exposed to GO, GR and their corresponding control samples with TMT isobaric tags 
[139]. Roughly 1500 proteins were unambiguously identified in the 3 biological 
replicates and more than 45% of them gave useful over/under expression data. A final list 
of 594 and 755 proteins were used for protein expression analysis for GR and GO 
treatment respectively. From this data set, more than 87% of the proteins showed a 
marked (>20% in the module) upregulation following GR/GO treatment and were 
subjected to PANTHER gene ontology analysis [140]. The pathways identified were then 
clusterized according to their corresponding biological process. Figure 15a reports the 
top 10 biological processes enriched in comparison with their corresponding controls for 
GR and GO respectively. The corresponding percent distribution, calculated on the basis 
of the total biological pathways mapped by PANTHER, is also reported. Intriguingly, the 
exposure of the same biological system to two different GRMs triggers the upregulation 
of different biological processes: mostly metabolism-related pathways for GR (32% of 
the total) and mostly trafficking-related pathways for GO (55% of the total). A close 
investigation of the proteins related to calcium metabolism, previously reported to be 
altered in neurons exposed to G materials [62] was also performed by using 
STRING[141]. As reported in Figure 15b, calmodulin (Calm1) shows opposite 
expression trends in GR (+21%) and GO (-31%). Some of its closest functional 
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interactors, such as calmodulin-binding proteins calponin 1 (Cnn1) and caldesmon 1 
(Cald1), are among the major upregulated proteins following GR treatment. Several other 
calcium-related proteins such as calcium-transporting ATPase1 (Atp2b1), calcium-
dependent-calmodulin stimulated phosphatase (Ppp3r2), Ca
2+
-binding proteins 
(calreticulin (Calr) and calumenin (Calu)), calcium and integrin binding family member 2 
(Cib2), calpain 2 (Capn2), and calnexin (Canx) are upregulated following exposure to 
GO. These preliminary results set the basis for further functional investigations, object of 
this thesis. 
 
 
Figure 15. Proteomic and lipidomic profiles of primary astrocytes exposed to GR and GO 
nanosheets. 
(a) Most upregulated biological processes following exposure of astrocytes to GR and GO. The 
percent value for each process is calculated on the basis of the total number of altered pathways 
detected by PANTHER. (b) Expression dynamics of Calmodulin protein interaction network 
following exposure to different GRMs, as reported by STRING. (Bramini et al, unpublished 
data).  
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3. AIM OF THE THESIS 
G-related materials are the focus of intense research efforts to devise novel nanomaterial-
based theranostic strategies for targeting the CNS. Previous work published by our group 
pointed the attention on effects of GO nanosheets on neuronal network transmission and 
functionality, warning on the safety of G materials once in contact with neuronal cells. 
However, brain parenchyma is composed also of other cells besides neurons, namely glial 
cells, which are involved in fundamental activities related to maintaining the functional 
and structural homeostasis of the CNS. Thus, to support the view that G could be a 
suitable material for neurobiology application in vivo, its biocompatibility with glial cells 
must also be tested. Thus, we extended the study of the bio-interactions of GR and GO 
nanosheets in CNS by addressing the effects of nanosheet exposure on primary 
astrocytes.  
Considering the different properties of the two G materials analyzed (i.e lateral 
size, layer number, surface charge), we expect to detect a different biological response. A 
complete analysis was conducted for each material by exploring (i) the molecular 
mechanisms of G nanosheets internalization, (ii) the effects of G exposure on cell 
morphology and physiology and  (iii) the physiological changes induced by nanosheet-
exposed astrocytes to co-cultured primary neurons. The investigation of astrocyte 
response to G and GRMs will be helpful to find novel nanotechnology-based therapeutic 
strategies for a variety of CNS conditions, and it is at the same time necessary to 
understand whether exposure to GRMs can lead to the onset of pathologies of astrocytes 
per se or due to alterations in glia-neuron interaction.  
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4.MATERIALS AND METHODS 
Preparation of primary astrocytes and astrocyte/neuron co-coltures. 
All experiments were carried out in accordance with the guidelines established by the 
European Community Council (Directive 2010/63/EU of 22 September 2010) and were 
approved by the Italian Ministry of Health (Authorization #306/2016-PR on March 24, 
2016). Primary cultures were prepared from wild-type Sprague-Dawley rats (Charles 
River, Calco, Italy). All efforts were made to minimize suffering and to reduce the 
number of animals used. Rats were sacrificed by CO2 inhalation, and 18-day embryos 
(E18) were removed immediately by caesarean section. Briefly, enzymatically 
dissociated astrocytes were plated on poly-D-lysine-coated (0.01 mg/ml) cell culture 
flasks and maintained in a humidified incubator with 5% CO2 for 2 weeks. At confluence 
astrocytes were enzymatically detached using trypsin–EDTA and plated on glass 
coverslips (Thermo-Fisher Scientific, Waltham, MA) at a density of 20,000-40,000 
cells/ml, depending on the experiment. Cultures were incubated at 37 °C, 5% CO2, 90% 
humidity in medium consisting of DMEM (Gibco/Thermo-Fisher Scientific) 
supplemented to reach final a concentration of 5% glutamine, 5% penicillin/streptomycin 
and 10% Foetal Bovine Serum (FBS; Gibco/Thermo-Fisher Scientific). For experiments 
involving G treatments, cultures were incubated at 1 day in vitro (DIV) in a medium 
containing either 1 or 10 µg/ml of either GR or GO nanosheets. Control samples were 
subjected to the same medium change with the addition of equivalent volumes of the 
respective vehicle (0.09 ppm melamine/H2O for GR flakes, H2O for GO flakes). Cultures 
were used at DIV 2, 4 and 8 (i.e., after 24 h, 72 h and 7 days of GR/GO incubation, 
respectively). For experiments involving astrocyte/neuron co-cultures, astrocytes were 
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seeded on poly-D-lysine-coated (0.01 mg/ml) glass coverslips at a density of 40,000 
cells/ml. After 72 h of incubation with GR/GO or the respective vehicle (see above), 
enzymatically dissociated cortical neurons obtained from 18-day rat embryos (E18) were 
plated on the top of astrocytes at a density of 40,000 cells/ml in Neurobasal 
(Gibco/Thermo-Fisher Scientific) supplemented to reach a final concentration of 5% 
glutamine, 1% penicillin/streptomycin, and 2% B27 (Gibco/Thermo-Fisher Scientific). 
All chemicals were purchased from Life Technologies/Thermo-Fisher Scientific unless 
stated otherwise. All experiments on co-cultures were performed at 10 DIV. 
 
Immunofluorescence staining and confocal imaging. 
Primary astrocytes were fixed in phosphate-buffered saline (PBS)/4% paraformaldehyde 
(PFA) for 20 min at RT. Cells were permeabilized with 1% Triton X-100 for 5 min, 
blocked with 2% FBS in PBS/Tween 80 0.05% for 30 min at RT and incubated with 
primary antibodies in the same buffer for 45 min. The primary antibodies used were: 
rabbit polyclonal anti-Iba1 (#01919741, Wako, Japan), mouse monoclonal anti-glial 
fibrillary acidic protein (GFAP, #G3893, Sigma-Aldrich, Milan, Italy), guinea pig 
polyclonal anti-vesicular glutamate transporter-1 (VGLUT1, #AB5905, Millipore, Milan, 
Italy), rabbit polyclonal anti-vesicular GABA transporter (VGAT, #131003, Synaptic 
System, Gottingen, Germany), rabbit polyclonal anti-microtubule-associated protein 
1A/1B-light chain 3 (LC3, #2775, Cell Signaling Technology, Danvers, Massachusetts, 
USA), rabbit polyclonal anti-astrocyte potassium channel KIR4.1 (KIR4.1, #APC-035, 
Alomone, Jerusalem, Israel) and rabbit polyclonal anti-glutamate transporter 1 (EAAT2, 
#3838, Cell Signaling Technology). After the incubation with primary antibodies and 
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several PBS washes, neurons were incubated for 45 min with the secondary antibodies in 
blocking buffer solution. Fluorescently conjugated secondary antibodies were from 
Molecular Probes (Thermo-Fisher Scientific; Alexa Fluor 488 #A11029, Alexa Fluor 568 
#A11036, Alexa Fluor 647 #A21450). Samples were mounted in ProLong Gold antifade 
reagent with DAPI (#P36935, Thermo-Fisher Scientific) on 1.5 mm-thick coverslips. For 
EEA1, LAMP1, VGLUT1/VGAT-positive terminals and LC3 vesicles, image acquisition 
was performed using a confocal laser scanning microscope (SP8, Leica Microsystems 
GmbH, Wetzlar, Germany) at 63x (1.4 NA) magnification. Z-stacks were acquired every 
300 nm; 10 fields/sample (n=2 coverslips/sample, from 3 independent culture 
preparations). Offline analysis was performed using the ImageJ software and the JACoP 
plugin for co-localization studies. For each set of experiments, all images were acquired 
using identical exposure settings. For VGLUT and VGAT quantification experiments, 
values were normalized to the relative cell volume calculated on the basis of -tubulin III 
labeling. For cholesterol investigation, filipin (F-9765, Sigma-Aldrich) staining was 
carried out. Briefly, cells were fixed as described above and incubated with 1.5 mg/ml of 
glycine in PBS for 10 min at RT to quench the PFA. Cells were incubated for 2 h at RT 
with 0.05 mg/ml of filipin in 10% FBS-PBS solution. Images were acquired at a confocal 
microscope at 63x (1.4 NA) magnification, using 405 nm excitation wavelength and 
filter-set 430 nm long pass filter. For sodium azide (NaN3) experiments, cells were 
treated with 1 mg/ml NaN3 (Sigma-Aldrich) for the all the time of G exposure. 
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Scanning and Transmission Electron Microscopy. 
For scanning electron microscopy (SEM) analysis, primary astrocytes treated with 
GR/GO nanosheets or with the respective vehicle for 24 h, 72 h and 7 days were fixed 
with 1.5% glutaraldehyde in 66 mM sodium cacodylate buffer and post-fixed in 1% 
OsO4. Sample dehydration was performed by 5 min washes in 30%, 50%, 70%, 80%, 
90%, 96% and 100% EtOH solutions. In order to fully dry the samples, overnight 
incubation with 99% hexamethyldisilazane (HMDS) reagent (#440191, Sigma-Aldrich) 
was performed. Before SEM acquisition, coverslips were sputter-coated with a 10 nm 
layer of 99% gold (Au) nanoparticles in an Ar-filled chamber (Cressington, Sputter 
Coater 208HR), and imaged using a JEOL JSM-6490LA scanning electron microscope. 
For transmission electron microscopy (TEM) analysis, astrocytes treated with GR/GO 
nanosheets or with the respective vehicle for 24 h, 72 h and 7 days were fixed with 1.2% 
glutaraldehyde in 66 mM sodium cacodylate buffer, post-fixed in 1% OsO4, 1.5% 
K4Fe(CN)6 0.1 M sodium cacodylate, en bloc stained with 1% uranyl acetate dehydrated 
and flat embedded in epoxy resin (Epon 812, TAAB). After baking for 48 h at 60 °C, the 
glass coverslip was removed from the Epon block by thermal shock using liquid N2. 
Astrocytes were identified by means of a stereomicroscope, excised from the block and 
mounted on a cured Epon block for sectioning using an EM UC6 ultramicrotome (Leica 
Microsystem). Ultrathin sections (70 nm thick) were collected on copper mesh grids and 
observed with a JEM-1011 electron microscope operating at 100 kV and equipped with 
an ORIUS SC1000 CCD camera (Gatan Inc., Pleasanton, CA). For each experimental 
condition, at least 6 images were acquired at a magnification up to 10,000x. Electron 
microscopy experiments were performed by Dr. Bramini (IIT-NSYN, Genova). 
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Patch-clamp electrophysiology. 
All experiments were performed using an EPC-10 amplifier controlled by the 
PatchMaster software (HEKA Elektronik, Lambrecht/Pfalz, Germany) and an inverted 
DMI6000 microscope (Leica Microsystems GmbH). Patch electrodes fabricated from 
thick borosilicate glasses were pulled to a final resistance of 4−5 MΩ. Recordings with 
leak current > 100 pA were discarded. All recordings were acquired at 50 kHz. Primary 
rat cortical astrocytes exposed for 72 h to GR/GO nanosheets (1 and 10 μg/mL) or to the 
respective vehicle were used for patch-clamp recordings. The standard bath saline 
contained (in mM): 140 NaCl, 4 KCl, 2 MgCl2, 2 CaCl2, 10 HEPES, 5 glucose, pH 7.4, 
with NaOH and osmolarity adjusted to ∼ 315 mOsm with mannitol. The intracellular 
(pipette) solution was composed of (in mM): 144 KCl, 2 MgCl2, 5 EGTA, 10 HEPES, pH 
7.2 with KOH; osmolarity ∼ 300 mOsm. Experiments were carried out at RT (20–24°C). 
For co-culture experiments, primary rat cortical neurons were seeded on top of 
astrocytes previously exposed to GR/GO flakes for 72 h (10 μg/mL) or to the respective 
vehicle and used for patch-clamp experiments after 10 DIV. Recordings of evoked firing 
activity in current-clamp configuration were performed in Tyrode’s extracellular solution 
in which D-(−)-2-amino-5-phosphonopentanoic acid (AP5, 50 μM), 6-cyano-7 
nitroquinoxaline-2,3-dione (CNQX, 10 μM), bicuculline methiodide (BIC, 30 μM), and 
(2S)-3-[[(1S)-1-(3,4-Dichlorophenyl)ethyl]amino-2-hydroxypropyl](phenylmethyl) 
phosphinic acid hydrochloride (CGP, 5 µM) were added  to block NMDA, non-NMDA, 
GABAA, and GABAB receptors, respectively. The internal solution (K-gluconate) was 
composed of (in mM): 126 K gluconate, 4 NaCl, 1 MgSO4, 0.02 CaCl2, 0.1 BAPTA, 15 
glucose, 5 Hepes, 3 ATP, and 0.1 GTP, pH 7.3. Current-clamp recordings were 
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performed at a holding potential of −70 mV, and action potential firing was induced by 
injecting current steps of 10 pA lasting 500 ms. All parameters were analyzed using the 
Fitmaster (HEKA Elektronik,) and Prism6 (GraphPad Software, Inc.) software. 
Spontaneous miniature excitatory postsynaptic (mEPSCs) currents and 
spontaneous miniature inhibitory postsynaptic (mIPSCs) currents were recorded in 
voltage-clamp configuration in the presence of tetrodotoxin (TTX, 300 nM) in the 
extracellular solution to block the generation and propagation of spontaneous action 
potentials. To isolate mEPSCs currents, 30 M BIC was added to Tyrode’s extracellular 
solution, in the presence of the internal solution (K-gluconate) described above. To 
isolate mIPSC currents, 10 μM CNQX was added to Tyrode’s extracellular solution, in 
presence of internal solution composed of (in mM): 120 KGluconate, 4 NaCl, 20 KCl, 1 
MgSO4, 0.1 EGTA, 15 Glucose, 5 HEPES, 3 ATP, 0.1 GTP (pH 7.2 with KOH). mPSCs 
were acquired at 10 kHz sample frequency, filtered at half the acquisition rate with an 8-
pole low-pass Bessel filter, and analyzed by using the Minianalysis program 
(Synaptosoft, Leonia, NJ, USA). The amplitude, frequency, rise time and decay time of 
mPSCs were calculated using a peak detector. All reagents were purchased from Sigma 
Aldrich or Tocris (Tocris, Avonmouth, Bristol, UK). 
 
Protein extraction and western blotting analysis. 
Total protein lysates were obtained from cells lysed in RIPA buffer (10 mM Tris-HCl, 1 
mM EDTA, 0.5 mM EGTA, 1% Triton X-100, 0.1% sodium deoxycholate, 0.1% sodium 
dodecyl sulfate, 140 mM NaCl) containing protease and phosphatase inhibitor cocktails 
(Roche, Monza, Italy). The soluble fraction was collected and protein concentration was 
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determined using the BCA Protein Assay Kit (Thermo-Fisher Scientific). For Western 
blotting, protein lysates were denatured at 99 °C in 5X sample buffer (62.5 mM Tris-
HCL, pH 6.8, 2% SDS, 25% glycerol, 0.05% bromophenol blue, 5% -mercaptoethanol, 
deionized water) and separated on SDS-polyacrylamide gels (SDS-PAGE). The 
following antibodies were used: mouse monoclonal anti-LC3 (#0231, Nanotools, 
Teningen, Germany), mouse monoclonal anti-glial fibrillary acidic protein (GFAP, 
#G3893, Sigma-Aldrich), rabbit polyclonal anti-astrocyte potassium channel KIR4.1 
(KIR4.1, #APC-035, Alomone) and rabbit polyclonal anti-glutamate transporter 1 
(EAAT2, #3838, Cell Signaling Technology). Signal intensities were quantified using the 
ChemiDoc MP Imaging System (GE Healthcare BioSciences, Buckinghamshire, UK). 
 
Calcium imaging. 
Cultures were loaded for 30 min at 37 °C with 1 μg/ml cell-permeable Fura-2 AM 
(#F1221, ThermoFisher Scientific) in the culture medium. Cells were then washed in 
recording buffer (140 NaCl, 4 KCl, 2 MgCl2, 2 CaCl2, 10 HEPES, 5 glucose, pH 7.4, 
with NaOH) for 30 min at 37 °C to allow hydrolysis of the esterified groups. Coverslips 
with cells were mounted on the imaging chamber and loaded with 0.5 ml of recording 
buffer. Fura-2-loaded cultures were observed with an inverted epifluorescence 
microscope Leica DMI6000 (Leica Microsystems GmbH) using a 63x (1.4 NA) oil-
immersion objective, and recordings were performed from visual fields containing 5 ± 2 
astrocytes on average. During the analysis, we selected the cells by drawing regions of 
interest (ROI) around their bodies to reduce any background. Samples were excited at 
340 and 380 nm by a mercury metal halide lamp, LEICA EL6000 (Leica Microsystems 
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GmbH). Excitation light was separated from the emitted light using a 395 nm dichroic 
mirror. Images of fluorescence emission > 510 nm were acquired continuously for a 
maximum of 2400 s (200 ms individual exposure time) by using a Hamamatsu Orca-ER 
IEEE1394 CCD camera (Hamamatsu Photonics, Hamamatsu City, Japan). The imaging 
system was controlled by an integrating imaging software package (Leica LAS AF 
software, Leica Application Suite Advance Fluorescence, version 3.3, Leica 
Microsystems). In order to monitor spontaneous Ca
2+
 oscillations, astrocytes were 
recorded for 15 min under baseline conditions. For ATP (#A2383, Sigma-Aldrich) 
experiments, after 1 min of baseline acquisition, astrocytes were stimulated with 10 µM 
of ATP. For thapsigargin (#1138, Tocris), experiments, cells were perfused with a 
standard Ca
2+
-free extracellular solution in which Ca
2+
 was replaced with 5 mM EGTA, 
after 30 sec of baseline acquisition, 5 µM of thapsigargin was added. After [Ca
2+
]i 
returned to baseline levels, EGTA was replaced by CaCl2 (2 mM) in the extracellular 
medium to induce Ca
2+
 entry. 
Fluorescence intensity ratios (R) were calculated for the time course of the 
experiment according to the equation below: 
 
𝑅 =
𝑀𝑉 (𝜆𝑥340 − 𝜆𝑒510) − 𝑀𝑉 𝑏𝑎𝑐𝑘𝑔𝑟𝑜𝑢𝑛𝑑 
𝑀𝑉 (𝜆𝑥380 − 𝜆𝑒510) − 𝑀𝑉 𝑏𝑎𝑐𝑘𝑔𝑟𝑜𝑢𝑛𝑑
 
 
where MV (mean value) is the average pixel intensity for each ROI, and λx-λe is the 
excitation (collection) wavelength. For quantitative analysis, the percentage total increase 
fluorescence signal (ΔF) was calculated by subtracting F0 and ΔF, and normalized to F0 
fluorescence values. 
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Glutamate uptake assay. 
For glutamate uptake experiments, astrocytes were plated at concentration of 1 x 10^5 
cell/ml in 6 well plate. Astrocytes cultures were washed three times with pre-warmed 
(37°C) HEPES-buffered Hanks' balanced salt solution, 1 μCi/ml of l-[2.3-3H]glutamate 
(NET490001MC, Perkin Elmer, Milan, Italy) was added to unlabeled l-glutamate 
(#G8415, Sigma) to a final concentration of 50 μM. To isolate Na+-dependent transport, 
cultures were exposed to 1μCi/ml of l-[2.3-3H]glutamate in the presence or absence of 
Na
+
. In the Na
+
-free buffer, NaCl was replaced by choline chloride (Sigma). To isolate 
Kir4.1 mediated glutamate uptake, 100 M Ba
2+
 (Sigma) was added to Na
+
 solution. To 
block glutamate transporters 100 M TBOA (Tocris) was added to Na
+
 solution. Cultures 
were incubated with the isotope on a heating plate at 37°C for 10 min. After three washes 
with PBS, cells were harvested into 400 ml of 1 M NaOH solution. The samples for 
radioactivity detection were transferred to vials containing 2 ml of aqueous scintillation 
mixture and counted using a liquid scintillation counter (1450 LSC & Luminescence 
Counter, MicroBete TriLux, Perkin Elmer).  
 
Statistical Analysis. 
Data are expressed as means ± SEM of number of cells (n) and mouse preparations 
detailed in the figure legends. Normal distribution of data was assessed using the 
D’Agostino-Pearson’s normality test (for n>8 values/experimental group) or the 
Kolmogorov–Smirnov test (n<8 values/experimental group). Significance level was 
preset to p<0.05. To compare two normally distributed sample groups, data were 
analyzed by the paired/unpaired Student’s t-test or, in case of more than 2 experimental 
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groups, by one- or two-way analysis of variance (ANOVA) followed by the Bonferroni's 
post-hoc multiple comparison test. To compare two groups that were not normally 
distributed, the Mann–Whitney’s non-parametric U test was used, while in case of more 
than 2 experimental groups, the Kruskal-Wallis test followed by Dunn’s post hoc test was 
performed. Statistical analysis was carried out using the Prism (GraphPad) software. 
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5. RESULTS 
5.1 GR and GO nanosheets induce morphological changes in primary 
astrocytes due to reorganization of cell cytoskeleton. 
We firstly evaluated whether G nanosheets could alter glial morphology. To this end, 
parallel samples were processed for confocal laser-scanning microscopy (CLSM) using 
antibodies specific for the glial cytoskeleton (anti-glial fibrillary acidic protein; GFAP) 
and Hoechst staining to visualize nuclei, or subjected to scanning electron microscopy 
(SEM) (Figure 1a). Fluorescence microscopy revealed that exposure to G sheets induced 
a clear change in the shape of astrocytes that, from regular and flat-shaped (typical of 
non-activated in vitro cultured primary astrocytes), became irregular and characterized 
by multiple thin processes and elongated protrusions, resembling the morphology of in 
vitro activated/mature glia [142, 143]. To quantitatively analyze this phenomenon, we 
employed the circularity index (ImageJ) as measure of symmetry and regularity of the 
cell shape. Figure 1b shows that upon exposure to G nanosheets, astrocytes are 
characterized by a significantly lower index, indicative of a more elongated and 
asymmetrical shape. 
The observed morphological transformation could be due to nanosheet-induced 
cytoskeletal reassembling [144], a phenomenon reported also for other carbon materials 
[145]. To confirm this hypothesis, astrocytes were fixed and stained after 72 h of G 
exposure using fluorescently labeled phalloidin to visualize actin filaments and 
antibodies for microtubules (anti-α-tubulin). Three-dimensional Z-stack images were 
acquired by CLSM, adopting the reflection light acquisition modality to visualize G 
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nanosheets [62, 146]. Control cells showed well-organized actin and tubulin filament 
bundles, in contrast, G nanosheets induced breakdown of actin fibers (Figure 1c) and 
rearrangement of α-tubulin that irregularly aggregated upon G exposure (Figure 1 d). 
These data indicate that both GR and GO exposure alter the astrocyte cytoskeleton, 
driving the observed morphological changes. 
 
 
 
Figure 1. Interactions of GR and GO nanosheets with primary astrocytes. (a) GR and GO-
induced changes in cell morphology were investigated by SEM and fluorescence microscopy. 
Astrocytes were exposed to GR and GO nanosheets for 72 h, fixed and prepared for either SEM 
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analysis or confocal immunostaining with anti-GFAP antibodies (green)/Hoechst33342 (blue). 
Few nanosheets could be seen in adhesion to the cell membrane (white arrowheads, upper panel). 
Cell morphology of astrocytes exposed to GR and GO nanosheets was severely affected when 
compared to untreated samples. Scale bars, 50 μm. (b) Mean ± SEM of circularity index for each 
experimental condition. ***p<0.001, one-way ANOVA and Bonferroni’s multiple comparison 
test, n = 130 cells, from 3 independent cell preparations. (c,d) Confocal images of astrocytes 
fixed and stained with phalloidin to visualize actin filaments (red, upper panel) and anti-αtubulin 
(red, low panel). Scale bars, 5 μm and 1 μm for low and high magnification, respectively. 
 
5.2 GR and GO nanosheets are mainly internalized through the 
endolysosomal pathway in the absence of autophagic reaction. 
To get more insights on the intracellular localization of the internalized nanosheets, the 
uptake rate and fate of GR and GO nanosheets were firstly investigated by quantifying 
the percentage of material overlapping with GFAP fluorescence using CLSM. The vast 
majority of astrocytes were found to internalize GR and GO nanosheets, with a very high 
amount of uptaken nanosheets already at 24 h of exposure (Figure 2a; mean ± SEM: GR 
40 ± 2.2%; GO 35 ± 1.1%). To identify the nature of the organelles containing the G 
nanosheets, we focused on the endo-lysosomal pathway, known to be the preferential 
route of entry of nanoparticles and nanomaterials [147-150]. Astrocytes were fixed after 
24 h, 48 h and 7 days of G nanosheet exposure, and labelled with antibodies for early-
endosomes (EEA1) and lysosomes (LAMP1). Three-dimensional Z-stack images were 
acquired and GR and GO were visualized using reflection light acquisition modality [62, 
146]. Following this procedure, a precise quantification of nanosheet uptake and 
intracellular location was possible (Figure 2b-e). The evaluation of the co-localization 
ratios between G and EEA1 or LAMP1 over the total amount of intracellular G revealed 
that the material was internalized with a time-dependent transition from EEA1-positive 
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early endosomes (up to 72 h) to LAMP1-positive lysosomes (Figure 2b-e). These results 
are in line with previous studies describing the intracellular trafficking of nanomaterials 
in living systems [148-151]. 
To better investigate the physical interaction of GR and GO nanosheets with glial 
cells, transmission electron microscopy (TEM) was used. The nanosheets were identified 
by their characteristic laminated shape, high electron-dense structure and typical 
reflected bright shadow in their proximity [152, 153]. As shown in Figure 2 f-h, both 
GR and GO flakes (black arrowheads) were present inside cells as aggregates of various 
sizes and compactness, mainly localized within membrane-bound vesicles (Figure 2g,h), 
possibly belonging to the endo-lysosomal pathway. As discussed above, the non-
homogenous nanosheets dispersion in solution may explain the formation of aggregates, 
although we cannot exclude that these agglomerates are formed inside cells, upon fusion 
of multiple vesicles into larger intracellular structures. 
Finally, the expression and maturation of LC3, a marker of autophagosome 
membranes, were investigated by immunofluorescence and western blotting (data not 
shown). Our results showed complete absence of LC3 in GR/GO treated astrocytes, 
opposite to what we observed in primary neurons, which upon G nanosheet exposure 
display a strong autophagy response [62]. 
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Figure 2. Interactions of GR and GO nanosheets with primary astrocytes. 
(a-e) Internalization of G nanosheets in primary astrocytes. Primary rat astrocytes were exposed 
to GR or GO nanosheets (10 g/ml) for 1, 3 and 7 days. Astrocytes were fixed and stained with 
anti-EEA1 and anti-LAMP1 antibodies for early endosome and lysosome identification, 
respectively, and Hoechst33342 for visualization of cell nuclei. (d, e) Astrocytes were imaged by 
confocal fluorescence microscopy and three-dimensional images were acquired (scale bars: 20 
m in main images, 2 m in zoomed images, 5 m in single-channel boxes). (a) Total internal 
GR and GO nanosheet internalization was quantified over time and expressed as percent uptake 
(meanSEM) with respect to the total G-nanosheets profile. Quantification of the extent of co-
localization of nanosheets with EEA1 (b) and LAMP1 (c) positive organelles analyzed using the 
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JACOP plugin of the ImageJ software (*p<0.05, **p<0.01, one-way ANOVA and Bonferroni’s 
multiple comparison test, 50 cells from n = 3 coverslips per experimental condition, from 3 
independent glial preparations). (f-h) The cell uptake of GR and GO and the intracellular location 
of G nanosheets were confirmed by TEM. Large nanosheets were found to be outside the cells in 
close proximity to the cell membrane (f). Large amounts of nanosheets (black arrowheads) were 
observed into intracellular vesicles, such as lysosomes (g) and larger lipid-containing vesicles (h). 
 
5.3 Exposure to GO alters calcium dynamics in primary astrocytes. 
As detailed in the Introduction, our proteomic analysis revealed a strong perturbation of 
the cellular pathways involved in Ca
2+
 homeostasis. To better understand these changes, 
we exposed primary astrocytes to G nanosheets for 72 h and then we investigated the 
effects of GR/GO on Ca
2+
 dynamics by live imaging using the ratiometric Ca
2+
 indicator 
Fura2-AM (Figure 3). Both GR- and GO-treated cultures were characterised by 
significantly lower basal Ca
2+ 
levels, by a smaller number of cells showing spontaneous 
[Ca
2+
]i transients (Figure 3a,b,e) as well as by a reduction in the frequency of [Ca
2+
]i 
oscillations (Figure 3c), although these effects reached statistical significance only for 
GO-treated astrocytes. Similar results were obtained when Ca
2+
 transients were evoked 
by stimulation of astrocytes with ATP, with a significantly impaired response by GO-
treated astrocytes (Figure 3d-f). 
To gain some insights into the mechanisms underlying the observed phenotype, 
we asked whether GO-exposure impairs the release of Ca
2+ 
from intracellular stores 
and/or the influx of Ca
2+
 from the extracellular medium [154]. To address this issue, we 
exposed GO-treated astrocytes to thapsigargin, a blocker of the SERCA pump that 
transports cytosolic Ca
2+
 into the endoplasmic reticulum, in Ca
2+
-free extracellular 
medium, to promote the depletion of the intracellular Ca
2+
 stores [155]. 
 
Interestingly, 
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under these conditions, GO-treated astrocytes showed an impaired response to 
thapsigargin, indicating defective Ca
2+
 storage mechanism. In addition, when the 
extracellular Ca
2+
 concentration was restored to 2 mM to assess Ca
2+
 entry through the 
plasma membrane calcium release activated channels (CRAC), GO-treated astrocytes 
displayed only a moderate increase in [Ca
2+
]i, which was significantly lower than that 
evoked in control astrocytes (Figure 3g,h). These results suggest the existence of a 
complex dysregulation of Ca
2+
 homeostasis and signalling in astrocytes exposed to GO 
nanosheets; the data are consistent both with the marked alterations of proteins involved 
in Ca
2+
 signalling depicted by the proteomic screening, and with the observed alterations 
of cytoskeleton [156]. 
It is well known that cholesterol, a constituent of lipid raft, is involved in the 
signaling between endoplasmic reticulum and plasma membrane refilling [157]. To verify 
whether the GO-induced dysregulation of Ca
2+
 homeostasis and signalling was associated 
with alteration in cholesterol content of the plasma membrane, we targeted membrane 
cholesterol by labelling primary astrocytes with the cholesterol-specific fluorescent 
marker filipin. Indeed, a significant two-fold increase in membrane cholesterol was 
observed in astrocytes treated with GO for 72 h with respect to control cultures (Figure 
4a, b). 
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Figure 3. Ca
2+
 dynamics in primary astrocytes treated with GR and GO nanosheets. 
(a) Representative spontaneous Ca
2+
 oscillations recorded in astrocytes treated with GR and GO 
nanosheets (10 μg/ml) for 72 h. Percentage of spontaneously active cells (b) and frequency of 
Ca
2+
 oscillations (c) under basal conditions. Means ± SEM of n=10 coverslips per experimental 
condition from 4 independent glial preparations (Ctrl, n = 32; GR, n = 31; GO, n = 23 cells). *p < 
0.05, one-way ANOVA/Bonferroni’s multiple comparison tests. (d) Representative Ca2+ 
responses evoked by ATP (10 µM) in astrocytes treated for 72 h with G-nanosheets. 
Quantification of the basal Ca
2+ 
levels (e) and changes in ΔF (i.e., [F-F0]/F0) values upon ATP 
addition (f). Means ± SEM of n=10 coverslips per experimental condition from 3 independent 
preparations (Ctrl, n = 21; GR, n = 25; GO, n = 21 cells). *p < 0.05, **p < 0.01 Kruskal-
Wallis/Dunn’s multiple comparison tests. (g) Representative traces of Ca2+ transients (left) and 
changes in ΔF values triggered by thapsigargin (TS, 1 µM) in Ca2+-free external medium (0 
[Ca
2+
]ext) and after replacement of the external solution with Ca
2+
-containing extracellular 
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medium (2 mM [Ca
2+
]ext). Means ± SEM of n=10 cells per experimental conditions from 3 
independent preparations. *p < 0.05, Mann Whitney U-test. 
 
 
Figure 4. Cholesterol content after GR and GO exposure. (a) Filipin staining was performed 
to investigate the cholesterol membrane distribution in untreated astrocytes (Ctrl) and astrocytes 
exposed to GR and GO nanosheets for 72 h. Cells were imaged by CLSM; scale bars, 20 μm. (b) 
Astrocytes treated with GR and GO displayed higher levels of filipin staining compared to control 
samples (means  SEM are shown; *p<0.05, **p<0.01, ***p<0.001; one-way ANOVA and 
Bonferroni’s multiple comparison test; n = 30 cells from 2 independent primary glial 
preparations). 
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5.4 Differential effects of GR and GO on the electrical membrane 
properties of cultured primary astrocytes. 
To assess whether GR and GO nanosheets affect astrocyte electrical membrane 
properties, we recorded K
+
 currents before and after chronic exposure to either GR or GO 
(1-10 µg/ml; 72 h) or their respective vehicles. It is well known in fact that cultured 
astrocytes express mainly outward rectifying K
+
 channels and, only upon their functional 
differentiation, they acquire a more physiological K
+
 current profile, owing to the 
additional expression of inward rectifier K
+
 channels (Kir) [158, 159]. Astrocytes were 
voltage clamped at a holding potential of − 60 mV and were challenged with a voltage 
ramp or step protocol (inset to Figure 5a,b). Typical current traces elicited with both 
protocols in astrocytes exposed to GR are shown in Figure 5a,b. The results show that 
the treatment with GR did not significantly affect the amplitude and slope of the ramp 
currents. Current density measured at 120 mV was not significantly different between 
GR-treated and vehicle-treated samples (25.1 ± 4.8 pA/pF for Ctrl, 29.4 ± 6.7 pA/pF for 
GR) (Figure 5c). Addition of barium (Ba
2+
, 100 µM), which prevalently blocks inwardly 
rectifying K
+
 channels [160], slightly inhibited (~ 20%) the current response at 120 mV 
to a similar extent in vehicle- and GR-treated astrocytes (Figure 5d). To unveil the time-
dependent kinetics of the elicited current, we then applied a step protocol. Upon step 
depolarization, rapidly activating and non-inactivating outward currents typical of 
delayed rectifier K
+
 conductance were evoked at potential more positive than -20 mV  
(Figure 5e). The voltage and temporal kinetics of the currents were not significantly 
different in vehicle- and GR-treated cells. Finally, analysis of the current-voltage 
relationship depicted a similar voltage-dependent profile between vehicle- and GR-
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treated astrocytes (Figure 5e). Compared to vehicle-treated astrocytes, GR exposure did 
not affect the resting membrane potential (-28 ± 6 mV for Ctrl, -35 ± 5 mV for GR), the 
input resistance (686 ± 51 MΩ for Ctrl, 756 ± 133 MΩ for GR), and the specific 
conductance (0.037 ± 0.005 nS/pF for Ctrl, 0.038 ± 0.005 nS/pF for GR) (Figure 5f-h). 
By contrast, an increase in outward rectifying current was observed in GO-treated 
astrocytes compared to vehicle-treated cells (Figure 5i,j). Analysis of current density 
values recorded at 120 mV showed an almost three-fold increase in GO-treated cells 
(26.9 ± 5.4 pA/pF for Ctrl, 67.1 ± 11.4 pA/pF for GO) (Figure 5k). Moreover, 
administration of Ba
2+
 produced a significantly larger (~ 40%) decrement of the ramp 
current measured at 120 mV compared to vehicle-treated astrocytes (Figure 5l). The time 
and voltage-dependent kinetics of the current evoked with the voltage stimulation 
protocol (Figure 5m) were similar under the two experimental conditions. The analysis 
of the current-voltage relationships shows that in GO-treated astrocytes there was an 
increment in current amplitude at negative membrane potentials (Figure 5m). Moreover, 
astrocytes exposed to GO nanosheets had a more hyperpolarized membrane potential (-
30.9 ± 6.5 mV for Ctrl and -50 ± 8 mV for GO), displayed a significant decrease in input 
resistance (706 ± 50 MΩ for Ctrl, 487 ± 67 MΩ for GO), and an increase in specific 
conductance (0.03 ± 0.003 nS/pF for Ctrl, 0.06 ± 0.01 nS/pF for GO) (Figure 5n-p). 
Similar results were obtained with lower doses (1 µg/ml) of GO, highlighting the 
specificity of this effect (Figure 6). These data suggest that Ba
2+
 sensitive, weakly 
rectifying Kir channels, which are upregulated in differentiated cultured cortical 
astrocytes, may be responsible for mediating, at least in part, the increase in outward 
current and the variation in passive membrane currents depicted in GO-treated astrocytes. 
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Figure. 5. Electrophysiological properties of astrocytes upon GR and GO nanosheet 
exposure. 
(a,b) Whole-cell patch clamp recordings of primary astrocytes exposed to GR. (a) Representative 
current traces evoked with a voltage ramp protocol in astrocytes treated for 3 days with either GR 
(10 µg/ml) or vehicle before (black traces) or after the addition of Ba
2+ 
(100 µM, red traces) to the 
recording medium. (b) Representative traces of whole-cell currents evoked with a family of 
voltage steps in astrocytes treated with GR (10 µg/ml) or vehicle. (c-e) GR exposure does not 
affect the characteristics of outward currents in astrocytes. (c) Mean ± SEM of current density 
values at 120 mV (n = 19 cells from 3 independent preparations). (d) Mean (± SEM) percentage 
of current inhibition at 120 mV after application of 100 µM Ba
2+ 
(n = 10 cells per experimental 
condition). (e) Current-voltage relationships in astrocytes exposed to GR (red) or vehicle (black). 
Data are plotted as means ± SEM (n = 12 cells from 3 independent preparations). (f-h) 
Electrophysiological properties of astrocytes treated for 72 h with GR (10 µg/ml). The parameters 
describing the passive membrane properties of astrocytes, i.e. resting membrane potential (mV; f) 
mean input resistance (MΩ; g), specific conductance (ns/pF; h), showed no significant changes. 
Means ± SEM of n = 19 cells per experimental condition from 3 independent preparations. (i-p) 
Whole-cell patch-clamp recordings of primary astrocytes exposed to GO. (i) Representative 
current traces evoked with a voltage ramp protocol in astrocytes treated for 72 hrs with either GO 
(10 µg/ml) or vehicle before (black traces) or after the addition of Ba
2+ 
(100 µM, red traces) to the 
recording medium. (j) Representative traces of whole-cell currents evoked with a family of 
voltage steps in astrocytes treated with GO (10 µg/ml) or vehicle. (k-m) GO exposure markedly 
increases outward K
+
 conductance in astrocytes. (k) Mean ± SEM current density values at 120 
mV. ***p< 0.001 Mann-Whitney U-test (n = 19 cells from 3 independent preparations). (l) Mean 
(± SEM) percentage of current inhibition at 120 mV after application of 100 µM Ba
2+
. *p < 0.05 
two-tailed Student's t-test (n = 10 cells per experimental condition). (m) Current-voltage 
relationships in astrocytes exposed to GO (red) or vehicle (black). Data are plotted as means ± 
SEM (n = 12 cells from 3 independent preparations). (n-p) GO exposure for 72 h affects the 
passive membrane properties of astrocytes. Resting membrane potential (mV; n), mean input 
resistance (MΩ; o), specific conductance (ns/pF; p), are shown as means ± SEM of n = 19 cells 
per experimental condition from 3 independent preparations. *p < 0.05, two-tailed Student's t-test. 
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Figure 6. Modulation of outward currents in astrocytes treated with 1 and 10 µg/mL of GO 
nanosheets. 
(a,b) Representative traces of whole-cell currents evoked in astrocytes treated for 72 h with GO 
(1 and 10 µg/ml) with a voltage ramp protocol (a) or a voltage-step protocol (b). (c) Summary of 
the mean (± SEM) passive membrane properties of astrocytes treated for 72 h with 1 and 10 
µg/ml GO. No significant changes were observed as a function of the GO concentration (1µg/ml 
GO, n=10; 10 µg/ml GO, n=19; from 3 independent preparations). 
 
5.5 GO effects on electrical membrane properties of cultured astrocytes 
are linked to the enhanced expression of Kir 4.1 channel. 
We next investigated whether the expression of Kir 4.1 channels, the main component of 
Kir current in astrocytes [76], was affected by G exposure. Primary astrocytes treated 
with either GR or GO nanosheets were stained with anti-Kir 4.1 antibodies. The 
fluorescence intensity was quantified in comparison with vehicle-treated samples (Figure 
7a,b). By avoiding the permeabilization step in the immunostaining procedure, we were 
able to monitor the expression of Kir 4.1 channels only on the plasma membrane, which 
represents the pool of functional channels. The results indicate that Kir 4.1 membrane 
labelling was markedly more intense and widespread in GO-treated astrocytes, whereas it 
65 
 
was indistinguishable from control astrocytes in GR-treated cells (Figure 7a,b). To 
confirm the immunofluorescence results, GO-treated and control astrocytes were 
solubilized and subjected to Western blotting for Kir 4.1. The total cell expression of Kir 
4.1 was increased upon exposure to GO nanosheets, with a significant upregulation of 
both the monomeric and tetrameric forms of the channel (Figure 7c-e). These data 
confirm that the increase in outward current and the variation in passive membrane 
currents in GO-treated astrocytes can be attributed to the enhanced expression of Kir 4.1 
channel.  
 
 
 
Figure 7. Kir 4.1 channel expression is increased in astrocytes upon exposure to GO 
nanosheets. (a,b) Primary astrocytes were exposed to GR and GO nanosheets (10 g/ml) for 72 
h, fixed and stained with anti-Kir 4.1 antibodies and Hoechst33342. (a) Astrocytes were imaged 
by confocal fluorescence microscopy and three-dimensional images were acquired (scale bars, 20 
m). (b) The mean  SEM intensity of Kir 4.1 immunoreactivity was calculated for each 
experimental condition. ***p<0.001, one-way ANOVA/Bonferroni’s multiple comparison tests 
(n = 40 cells from n = 2 coverslips per experimental condition from 2 independent preparations). 
(c-e) The overexpression of Kir 4.1 upon GO nanosheets exposure was confirmed by Western 
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blotting. (c) A representative experiment is shown, in which the tetrameric and monomeric forms 
of Kir 4.1 are electrophoretically resolved. Gapdh was used as loading control. Quantitative 
densitometry analysis of the immunoblots (means  SEM) shows the overexpression of both the 
tetrameric (d) and monomeric (e) forms of Kir 4.1. *p< 0.05, two-tailed Student's t-test (n = 3 
from 3 independent preparations). 
 
Kir 4.1 channels control extracellular homeostasis through the regulation of glutamate 
dynamics. In rat, the expression of Kir 4.1 has been linked to a positive modulation of 
glutamate clearance by astrocytes mediated by the Na
+
-dependent uptake through the 
GLT-1 transporter [112, 134]. To address the possibility that the increase in Kir 4.1 
current could increase glutamate clearance, we evaluated the ability of cultured astrocytes 
to uptake tritium-labeled glutamate (
3
H-Glu). Cultured astrocytes were exposed to GR or 
GO nanosheets for 72 h and then incubated with a mixture of labeled/unlabeled glutamate 
in Hank’s buffer, in the presence or absence of choline (to isolate the Na+-dependent 
glutamate transport) or following administration of Ba
2+
 (to inhibit Kir 4.1 channels) 
(Figure 8a). Interestingly, while GR did not promote any variation in glutamate uptake 
compared to control, GO-treated astrocytes showed a marked increase in their ability to 
clear glutamate. Importantly, in GO-treated cells both the replacement of Na
+
 and the 
challenge with Ba
2+
 diminished the glutamate uptake to the same extent as the treatment 
with 100 µM dl-threo-β-benzyloxyaspartic acid (DL-TBOA), which is a competitive 
blocker of glutamate transporters [161], indicating the strong contribution of Kir 4.1 to 
the Na
+
-dependent uptake of glutamate. We next investigated whether the increase in 
glutamate uptake could be due to enhanced expression of the GLT-1 transporter. 
Immunofluorescence analysis of treated and control cultures evidenced an increase in 
GLT-1 fluorescence in GO-treated astrocytes (Figure 8b), which was not evident in GR-
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treated astrocytes. In summary, these data support the view that the long-term challenge 
of cultured cortical astrocytes with GO produces an increment of their homeostatic 
capacity by regulating various cellular mechanisms involved in extracellular glutamate 
dynamics. 
 
 
Figure 8. Glutamate uptake is enhanced in GO-treated astrocytes. (a) Quantitative analysis of 
glutamate uptake of astrocytes after 72 h of GR and GO exposure. Data are normalized to 
untreated samples. Mean ± SEM of n = 3 independent preparations. *p<0.05, **p< 0.01 One-way 
ANOVA and Bonferroni’s multiple comparison test. (b) Representative images (upper panel, 
scale bar, 20 M) and quantification of EAAT2 immunoreactivity for each experimental 
conditions (lower panel). ***p<0.001 vs control samples, One-way ANOVA and Bonferroni’s 
multiple comparison test. Data are expressed as mean ± SEM of n = 30 cells, from 2 independent 
preparations. 
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5.6 GO nanosheets internalization causes shape changes and Kir 4.1 
channel upregulation in primary astrocytes. 
The effects of G nanosheets on the shape and electrical properties of primary astrocytes 
could be in principle attributable to membrane shear stress induced by macro-flakes 
adhering to the external surface of the membrane, or to active internalization of 
nanosheets. In the attempt to discern between these two possibilities and investigate a 
mechanistic explanation for the biological effects induced by GO, we examined the 
effects of G exposure under conditions in which nanosheet internalization is prevented. 
As a general non-specific blocker of endocytosis we used sodium azide, an ATPase 
inhibitor that is commonly used to block cell metabolism [162]. Primary astrocytes were 
pre-treated with low doses of sodium azide that inhibit endocytosis but do not cause cell 
death, and subsequently exposed to either GR or GO nanosheets for 72 h. Cells were then 
either fixed and processed for immunofluorescence (Figure 9a-e), or lysed and subjected 
to Western blotting for Kir 4.1 (Figure 9f-h). As reported above, exposure to either GR 
or GO nanosheets induced a shape change characterized by a sharp decrease of the 
circularity index, while the sodium azide treatment per se did not alter the shape with 
respect to vehicle-treated astrocytes. Interestingly, sodium azide treatment substantially 
rescued the shape and circularity index of astrocytes treated with both GR and GO 
(Figure 9b-d), a result likely due to the reduced flake internalization (Figure 9c-e). 
Notably, sodium azide pretreatment completely antagonized the upregulation of Kir 4.1, 
without altering its expression in vehicle-treated cells (Figure 9f-h). These results 
directly link GR/GO internalization to the observed changes in astrocyte shape and 
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plasma membrane K
+
 conductance, suggesting the uptake of the material is triggering the 
observed changes in physiological activity. 
 
 
 
Figure 9. Block of endocytosis with sodium azide reduces the internalization of GR and GO 
nanosheets, and rescues astrocyte shape changes and GO-induced Kir 4.1 channel 
overexpression. 
(a) Primary rat astrocytes were exposed to either GR or GO nanosheets (10 g/ml) for 72 h with 
or without prior incubation with 0.05% sodium azide (NaAz). Astrocytes were stained for GFAP 
and Hoechst33342 and imaged by CLSM. Representative three-dimensional images are shown 
(scale bars, 50 m). (b-e) The circularity index was quantified as a measure of the shape change 
of cells after GR (b) or GO (d) exposure. The amount of internalization of GR (c) and GO (e) 
flakes was also quantified. Means  SEM. *p<0.05, ***p<0.001, one-way ANOVA/Bonferroni’s 
multiple comparison tests (n = 100 cells from n = 2 coverslips per experimental condition, from 2 
independent preparations). (f-h) The expression of Kir 4.1 upon GO exposure with or without 
prior incubation with NaAz was investigated by Western blotting. (f) A representative 
immunoblot is shown with the resolved tetrameric and monomeric species of Kir 4.1 and Gapdh 
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used as loading control. Quantitative densitometric analysis of the immunoblots (means  SEM) 
shows that the increased levels of both tetrameric (g) and monomeric (h) species of Kir 4.1 are 
rescued upon NaAz treatment. *p<0.05, **p<0.01, two-tailed Student's t-test (n = 3 from 3 
independent preparations). 
 
5.7 Astrocytes primed for 72 h with GO nanosheets alter inhibitory 
synaptic transmission and intrinsic excitability of co-cultured primary 
cortical neurons. 
Astrocytes secrete factors involved in synaptogenesis, regulating the number of synapses 
[90, 91], postsynaptic activity [92] and presynaptic neurotransmitters release [93]. In 
addition, astrocytes are fundamental for maintaining brain homeostasis, and the 
dysregulation of K
+
 and glutamate uptake is linked to alteration of neuronal excitability 
and to the onset of neural disorders [163, 164]. Thus, having characterized the alteration 
of glia morphology and functionality by G nanosheet internalization, we extended our 
studies to an astrocyte-neuron co-culture system in order to understand the indirect effect 
of G exposure, by determining the influence of astrocyte dysregulation on neuronal cells. 
To determine the effect of G-treated astrocytes on neuronal synaptic transmission 
and synaptic density, glial cells were treated with GR and GO nanosheets for 72 h, and 
then primary cortical neurons were plated on top of the astrocyte layer. We performed 
patch clamp recordings in neuronal cells at 10 DIV to monitor the frequency and 
amplitude of miniature excitatory (mEPSCs) and inhibitory (mIPSCs) postsynaptic 
currents. We found that the frequency and amplitude of mEPSCs were similar to control 
co-cultures under all the experimental conditions (Figure 10a-f). Double-staining of 
cortical neurons with antibodies for β-III tubulin to identify neuronal processes and the 
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vesicular glutamate transporter VGLUT1 to label excitatory synaptic contacts, revealed 
no difference in the density of excitatory synaptic contacts, supporting the 
electrophysiological data (Figure 10g). Surprisingly, we found a significant increase in 
mIPSCs frequency in GO samples in comparison with GR and control samples, in the 
absence of changes in the amplitude and in the current rise and decay times (Figure 10h-
l). To determine whether the changes in frequency were determined by an increase in the 
density of inhibitory synapses, we co-immunostained for β-III tubulin and VGAT to label 
inhibitory boutons, and found an higher density of inhibitory synaptic boutons in GO-
treated samples compared to GR-treated and control samples. These studies indicate that 
GO nanosheets influence the ability of astrocytes to promote formation and maturation of 
inhibitory GABAergic synapses (Figure 10m). 
We next assessed the intrinsic excitability of neurons in the co-culture system, a 
measure of maturation of voltage-dependent conductances in developing neurons. We 
performed patch-clamp recordings in current-clamp configuration by injecting constant 
current pulses of 500 ms of increasing amplitude of 10 pA and measuring the resulting 
action potential firing rate. The analysis of firing rate versus injected current revealed that 
GO treated astrocytes significantly enhanced the mean neuronal firing activity and the 
mean instantaneous firing frequency evoked by depolarizing current pulses in co-cultured 
neurons (Figure 11a-c). To better analyze the shape of the action potentials, we 
generated phase-plot graphs by plotting the first derivative of the membrane potential 
over time (dV/dt) versus membrane potential. The first component of the phase plot is due 
to spike initiation in the axon initial segment (AIS) and to its fast antidromic propagation 
to the soma that generates a sudden voltage increase from baseline called ‘kink’[165]. 
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The invasion of the soma by the AIS spike generates a delayed activation of Na
+
 channels 
in the somatodendritic portions that leads to the second component of phase-plot, the 
somatodendritic spike. Interestingly, phase-plots revealed a more prominent ‘kink’ in GO 
treated samples (Figure 11d). To quantify such differences, the changes in the kink were 
quantified by a linear regression fit of the 10 experimental points that follow the 
threshold, set at 5 mV/ms [165]. This analysis showed that the phase-slope was 
significantly increased in GO-treated samples (Figure 13e). Altogether, these results 
suggest that GO-treated astrocytes are able to influence the intrinsic excitability of 
cortical neurons by affecting voltage-gated channels expressed not only in the cell soma, 
but also at the AIS. 
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Figure 10. Astrocytes primed for 72h with GO nanosheets affect spontaneous activity of 
primary neurons. 
(a-g) Effects of GR and GO-treated astrocytes on miniature excitatory postsynaptic currents 
(mEPSCs). (a) Representative recordings of mEPSCs. (b) Cumulative distribution of inter-event 
intervals and mean ± SEM of mEPSCs frequency. (c) Cumulative distribution and mean ± SEM 
of mEPSC amplitude. (n = 10 cells from Ctrl, n = 10 cells for GR, n = 15 cells for GO, from 3 
independent preparations). (d) Density of VGLUT1-positive excitatory synapses (n = 30 cells, 
from 3 independent preparations). Mean ± SEM of mEPSC charge (e) rise (f) and decay time (g) 
(n = 10 cells from Ctrl, n = 10 cells for GR, n = 15 cells for GO, from 3 independent 
preparations). No statistically significant differences were observed amongst the various 
experimental groups. (h-p) Effects of GR/GO-treated astrocytes on miniature inhibitory 
postsynaptic currents (mIPSCs). (h) Representative recordings of mIPSCs. (i) Cumulative 
distribution of inter-event intervals and mean ± SEM frequency of mIPSCs (*p<0.05, one-way 
ANOVA and Bonferroni’s multiple comparison test, n = 10 cells per experimental condition from 
3 independent preparations). (l) Cumulative distribution and mean ± SEM of mIPSC amplitude. 
(m) Density of VGAT-positive inhibitory synapses (n = 30 cells, from 3 independent 
preparations; *p<0.05, one-way ANOVA and Bonferroni’s multiple comparison test). Mean ± 
SEM of mIPSC charge (n) rise (o) and decay time (p). No statistically significant differences 
were observed (n = 10 cells per experimental condition from 3 independent preparations). 
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Figure 11 Astrocytes primed for 72 h with GO nanosheets affect intrinsic excitability of 
primary neurons. 
(a-c) Effects of GR and GO-treated astrocytes on the firing properties of primary cortical neurons. 
(a) Representative traces of action potentials induced by the injection of 200 pA current steps for 
500 ms. Plots of the mean of firing frequency versus injected current per experimental conditions 
(b) and quantification of instantaneous firing frequency (c). Mean ± SEM of n = 21 cells for Ctrl, 
n = 15 cells for GR, n = 25 cells for GO, from 3 independent preparations (*p<0.05, **p<0.01, 
***p<0.001 two-way ANOVA and Bonferroni’s multiple comparison test). (d) Representative 
plots of the first derivative of the membrane voltage (dV/dt) versus membrane voltage (Vm) 
(phase-plots) per experimental condition. (e) Mean ± SEM of phase-slope measured at voltage 
more positive of 5 mV/ms. n = 21 cells for Ctrl, n = 15 cells for GR, n = 25 cells for GO, from 3 
independent preparations (*p<0.05, ***p<0.001, one-way ANOVA and Bonferroni’s multiple 
comparison test). 
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6. DISCUSSION 
The main objective of this study was to perform a detailed analysis of the effects of 
chronic exposure of G nanosheets on the biology of astroglial cells, which are the 
principal cellular interface of the neurons in the CNS and whose functionality deeply 
influences the neuronal network [166]. To date, this is the first study providing a 
thorough description of the biological interactions between G nanosheets and astroglial 
cells, and complements the information on the effects caused by the same materials on 
neuronal circuits in vitro [62]. Previous studies showed that the interaction with carbon 
related materials impact on the morphological and functional phenotype of astrocytes 
both in vitro and in vivo [145, 167], stressing the urgency of assessing a detailed toxicity 
profile for each specific material for future biomedical applications. Here we include a 
detailed characterization of astrocyte functionality upon GR and GO nanosheet exposure, 
combining different techniques ranging from cell biology to microscopy, 
electrophysiology, and live Ca
2+
 imaging. 
Although previous experiments showed that the viability of cultured astrocytes 
was not affected by long-term exposure to GR and GO up to 7 days of treatment, 
nanosheets caused marked morphological changes that shifted cells from an epithelioid to 
a differentiated phenotype. Treated astrocytes were characterized by the development of 
cytoplasmic processes with little ramifications, as previously observed in cells exposed to 
carbon nanotubes [145]. The observed G-induced morphological alterations resembled 
those of astrocytes that underwent long-term treatment with a membrane-permeable 
analogue of cyclic AMP [142, 159, 168, 169]. The relevance of this treatment to the in 
vivo situation is still matter of debate; indeed, cAMP-treated astrocytes have long been 
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considered as reactive astrocytes [169], whereas recent work suggests that they may 
reflect a more mature phenotype [142]. It is well known that reactive astrocytes display 
an increase in GFAP expression both in vitro and in situ [170, 171], which however was 
not found under our experimental conditions  upon exposure to G materials, (data not 
shown). This suggests that in our case the observed morphological changes were driven 
by nanosheet-mediated rearrangement of intracellular actin and tubulin filaments, in 
agreement with previous finding showing that GO nanosheets can insert into the inter-
strand gap of actin tetramers, leading to the disruption of actin filaments [172]. 
Notably, a larger amount of nanosheets were internalized by astrocytes compared 
to what we observed in neuronal cells [62]. Astrocytes possess a complex intracellular 
vesicular network that plays a fundamental role in both physiological and 
pathophysiological processes of the CNS [173]. The endo-lysosomal pathway resulted the 
preferential route of G-nanosheets intracellular trafficking. A significant percentage of 
material was internalized into endosomes within 24 h, ending up in lysosomes after 7 
days. Clearly, large flake aggregates (micrometer-size) remained mostly adherent to the 
cell membrane, while nanosheets were actively taken up and internalized. 
Thanks to proteomic and lipidomic analysis, we elucidated the specific effects of 
GR and GO nanosheets on major intracellular pathways. Interestingly, a close 
investigation of the proteins related to calcium metabolism, previously reported to be 
altered in neurons exposed to G materials [62], revealed that calmodulin (Calm1) and 
many other Ca
2+
-binding proteins were differentially altered after exposure to either GR 
and GO. Calmodulin is a Ca
2+
-binding protein that mediates the Ca
2+
 regulation of a wide 
range of physiological processes throughout the eukaryotic kingdom [174]. These data 
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drew our attention toward further and more detailed investigations. Astrocytes are indeed 
characterized by a complex modulation of Ca
2+
 events that coordinate their major 
functions, and in turn influence neuronal activity. They respond both in vitro and in situ 
to paracrine molecules released from neurons and other cell types of the CNS with 
fluctuations of intracellular Ca
2+
 levels, and inducing the release of a variety of diffusible 
molecules (called gliotransmitters) that can affect neuronal cells and interact in an 
paracrine fashion with neighboring astrocytes [84, 175]. One of the most important 
signaling molecules released in the extracellular milieu is ATP, which mediates 
astrocyte-to-astrocyte Ca
2+
-mediated communication, in particular via the activation of 
specific ligand gated P2X and G-protein-coupled metabotropic P2Y receptors [176]. Of 
note, astrocytes respond to ATP with a propagating wave of intracellular Ca
2+
, which 
underlies the synchronization of Ca
2+
 oscillations [177]. 
Our results showed that G nanosheets depress spontaneous Ca
2+ 
oscillations. This 
effect was statistically significant only for GO-treated astrocytes and was associated with 
a significant reduction of ATP-evoked Ca
2+
 transients. Since Ca
2+
 oscillations are linked 
to IP3-mediated Ca
2+
 release from endoplasmic reticulum [178, 179], this outcome could 
be attributable to a reduction of Ca
2+
 release from endoplasmic reticulum and/or Ca
2+
 
entry, because the influx of Ca
2+
 to refill the stores was also significantly depressed in 
astroglial cells exposed to GO. The relative contribution of the different pathways in the 
lower ATP response in GO-treated astrocytes will be clarify in future studies. The P2 
purinoceptor-mediated [Ca
2+
]i signaling is extremely complex [180]. In particular, P2X7 
and P2Y1 receptors are mainly involved in ATP-induced [Ca2
+
]i elevations, while 
additional receptors (i.e., P2X2, P2X4, P2X5, P2Y2, P2Y4, and P2Y14) may also contribute 
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to this phenomenon [181]. The mechanisms whereby GO affects Ca
2+
 signaling can only 
be speculated upon, and include an effect on membrane cholesterol [182] and cell 
cytoskeleton [156]. As a matter of fact, cholesterol is an important constituent of lipid 
rafts, which are membrane platforms involved in the signaling between endoplasmic 
reticulum and plasma membrane also in astroglial cells [157]. Our results are 
complementary to those generated in cell transfected with STIM1 and ORAi, which are 
essential molecular components of store-operated Ca
2+
 entry (SOCE), showing that 
depletion of membrane cholesterol causes an increase in SOCE signaling [182]. In this 
case, a dynamic interaction of STIM1 and ORAi, driven by cell cytoskeleton, is required 
for the correct intracellular signaling mediating Ca
2+
 influx [156]. Thus, we cannot 
exclude that the GO-mediated reorganization of actin and tubulin filaments plays a role in 
triggering the effects observed in our experimental system. 
An important result of this study is that long-term treatment of cultured astrocytes 
with GO (but not GR) changed the electrical passive properties of cultured astrocytes, 
which could be ascribed to the higher expression of a background K
+
 conductance. The 
functional and molecular properties of this K
+
 current were consistent with the activation 
of Kir 4.1 channels, and corroborated by immunocytochemical and western blot analyses, 
indicating that Kir 4.1 expression was augmented in GO-treated astrocytes compared to 
vehicle-treated cells. Kir 4.1 channels preferentially localize at cell processes and 
perivascular end-feets, and are responsible for maintaining glial negative resting 
membrane potential and high K
+ 
permeability [76]. In the literature, enhanced expression 
of Kir 4.1 has been associated with mature astrocytes [76], and with an increased 
glutamate uptake, which is favored by membrane hyperpolarization [183]. In agreement 
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with published data, we found an enhanced  Na
+
-dependent glutamate uptake specifically 
in GO-treated astrocytes, suggesting that the morphological and functional alterations 
induced by GO exposure are features of a more mature phenotype, resembling the in vivo 
situation. Interestingly, Kir 4.1 dysfunctions have been related to a variety of CNS 
pathologies, such as Huntington's disease [117], amyotrophic lateral sclerosis [115] and 
Alzheimer’s disease [81]. In addition, astrocytes of mice conditionally ablated of the 
KCNJ10 gene, the gene encoding Kir 4.1, show impairments in K
+
 channel activity and 
glutamate uptake associated with seizure susceptibility [184]. Thus, the physio-
pathological meaning of the effects of GO nanosheets on astrocytes has to be thoroughly 
evaluated and further investigations in vivo are needed to better clarify this point. 
Different putative mechanisms have been associated with G cytotoxicity [58]; in 
our case active internalization through energy dependent pathways seems to be the main 
cause of the above-described effects. This is suggested by the fact that the effects of GO 
nanosheets on cell morphology and ion channel expression were abrogated by inhibiting 
endocytosis upon pretreatment of cultured astrocytes with sodium azide [185], which 
indicates that internalization of GO nanosheets is necessary to promote its modulatory 
action. 
It is well-known that astrocytes shape neuronal network functions by maintaining 
the extracellular homeostasis trough K
+
 and glutamate clearance, and by regulating the 
properties of synapses thanks to a bidirectional signaling between neurons and astrocytes 
mediated by intracellular Ca
2+
 waves [166]. Thus, we expected that functional alterations 
in astrocytes could affect neuronal network properties. To verify this hypothesis, we 
performed astrocytes neuron co-cultures and monitored electrophysiological properties of 
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neurons cultured for 10 DIV on G-treated astrocytes. We found an increase in frequency 
of spontaneous inhibitory postsynaptic current accompanied by an increase of inhibitory 
synaptic density specific for GO treated samples. These results indicate that astrocytes, 
after long term GO treatment, selectively promote the formation and functional 
maturation of inhibitory GABAergic synapses via secreted factors, an effect previously 
reported to be mediated by neurotrophin signaling [186]. In addition, GO-treated 
astrocytes significantly enhanced neuronal firing activity evoked by depolarizing current 
pulses. A possible explanation for this phenomenon is that astrocytes exposed to GO 
accelerate the functional maturation of neuronal cells, affecting voltage-gated channels 
expressed not only in the cell soma, but also at the AIS. 
This is not the first study addressing the interaction of astroglial cells with 
nanomaterials. In previous work, mouse cortical astrocytes grown on a single-walled 
carbon nanotube films displayed an increase in their proliferative rate, a dedifferentiated 
morphological phenotype and a decrease in GFAP immunoreactivity [145, 187] ,which 
was interpreted as a nonreactive phenotype. By contrast, the same nanomaterial delivered 
as colloidal solute promoted the stellation of cultured astrocytes, an increase in GFAP 
immunoreactivity [188] and an increment in glutamate uptake [167]. Cortical astrocytes 
plated on synthetic polyamide nanofibers were reported to acquire a stellate morphology 
caused by activation of Rho GTPases [189] and to promote neurite outgrowth when co-
cultured with neurons [190]. This result was associated to the ability of astrocytes grown 
onto the above-mentioned nanofibers to secrete growth factors into the medium [191]. 
Whether G nanosheets may also act by stimulating the release of growth factors from 
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astrocytes to influence the electrical activity of neighboring neurons remains to be 
addressed. This is another issue to be addressed in our future investigations.  
In conclusion, our analysis revealed that, although exposure to G nanosheets does 
not impact primary astrocyte viability, it has important effects on their functionality and 
on the physiology of co-cultured neuronal cells. In particular, GO nanosheets, which are 
the most promising material for biological applications, have a much higher impact on 
astrocyte cells with respect to GR nanosheets, probably due to their surface charge and 
higher surface area and reactivity with the biological environment. On one hand, these 
data raise some concern about the safety of GO nanosheets, suggesting that GR 
nanosheets are safer in a biological framework. On the other hand, however, our data 
indicate that the observed GO-induced morphological and functional alterations could be 
attributed to a more mature astrocyte phenotype rather than to a reactive condition. In 
addition, considering that potassium and glutamate homeostasis play an important role in 
regulating neuronal excitability, we can speculate that the increase in potassium and 
glutamate uptake induced by GO nanosheets could have a neuroprotective role, favorable 
to prevent the development of seizures and cell death. Furthermore, the possibility of GO 
nanosheets to be functionalized with polyethylene glycol (PEG), poli(ε-caprolactone) 
(PCL), pluronic, amine, carboxyl and dextran groups to decrease toxicity and increase 
biocompatibility plays definitely a major role for further safer applications. 
Future studies in vivo will address whether GR/GO nanosheets are beneficial or 
detrimental for the functionality of the CNS and could be used safely for different 
purposes in clinical neuroscience. A schematic model, summarizing the most relevant 
finding of this work, is reported in Figure 12. 
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Figure 12. Schematic representation of the effects of chronic exposure of GO in primary 
astrocytes. 
A. Increase in membrane cholesterol and alteration of cell cytoskeleton impact on Ca
2+
 
homeostasis. B. Upregulation of Kir4.1 and GLT1 shapes extracellular homeostasis. C. 
Functional alterations in astrocytes accelerate the maturation of neuronal functional properties, 
including increase in mIPSC frequency and firing activity. 
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7. FUTURE PERSPECTIVES 
In future, as follow up of the investigation of G interactions with the CNS, we plan to 
proceed with in vivo brain administration of G (intra-cerebroventricular and intra-
parenchimal) to the mouse and study: i) inflammatory response triggered by astrocytes 
and microglia cells; ii) the behavioral, functional and “omics” profiles in vivo; and iii) the 
physiology of well characterized neuronal circuits (e.g. hippocampus, cerebellum) in 
acute ex vivo brain slices. This will allow researchers to have a complete overview over 
the bio-interactions of this innovative material with the CNS, ranging from detailed in 
vitro studies, to understand the cellular and molecular mechanisms of interactions, to in 
vivo exposure to investigate a more physiological situation and have a better picture of 
the physiological effects of graphene. The final aim will be to understand the biological 
behavior of G, in order to engineer the material and increase its biocompatibility to 
address biomedical applications. 
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Extracellular pH impacts on neuronal activity, which is in turn an important determinant 
of extracellular H
+
 concentration. The aim of this study was to describe the spatio-
temporal dynamics of extracellular pH at synaptic sites during neuronal hyperexcitability. 
To address this issue we created ex.E
2
GFP, a membrane-targeted extracellular ratiometric 
pH indicator that is exquisitely sensitive to acidic shifts. By monitoring ex.E
2
GFP 
fluorescence in real time in primary cortical neurons, we were able to quantify pH 
fluctuations during network hyperexcitability induced by convulsant drugs or high 
frequency electrical stimulation. Sustained hyperactivity caused a pH decrease that was 
reversible upon silencing of neuronal activity and located at active synapses. This acidic 
shift was not attributable to the outflow of synaptic vesicle H
+
 into the cleft nor to the 
activity of membrane-exposed H
+
 V-ATPase, but rather to the activity of the Na
+
/H
+
-
exchanger. Our data demonstrate that extracellular synaptic pH shifts take place during 
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epileptic-like activity of neural cultures, emphasizing the strict links existing between 
synaptic activity and synaptic pH. This evidence may contribute to the understanding 
of the physio-pathological mechanisms associated with hyperexcitability in the epileptic 
brain. 
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ABSTRACT  
Through their ability to modulate synaptic transmission, glial cells are key regulators of 
neuronal circuits formation and activity. Kidins220/ARMS (Kinase-D interacting 
substrate of 220 kDa/Ankyrin repeat-rich membrane spanning) is one of the key effector 
proteins of the neurotrophin pathways in neurons where it is required for differentiation, 
survival and synaptic plasticity. However, its role in glia remains largely unknown.  
Here, we showed that ablation of Kidins220 in astrocytes induces defects in BDNF-
dependent TrkB signaling, as well as calcium signalling impairments. Survival and death 
pathways were also affected, as Kidins220
-/-
 astrocytes displayed (i) impaired proBDNF-
dependent activation of NFkB and caspase pathways, and (ii) were more sensitive to 
genotoxic stress. Furthermore, using neuro-glia co-cultures we showed that wild type 
neurons grown on Kidins220-/- astrocytes presented dendritic arborization defects and a 
delayed formation of GABAergic synapses compared to those grown on wild type cells. 
Altogether, our data reveal a previously unidentified role for astrocyte-expressed 
Kidins220 in the modulation of survival/death pathways in glial cells, as well as in the 
control of astrocyte-neuron communication. 
 
